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whether creation and subsequent closure of ASD would be feasible solely under RT3DE 
guidance.
Methods: In a pig model (n=5) a 4-10 mm ASD was created with a balloon catheter 
and enlarged with a punch. Philips Sonos 7500 system with epicardially positioned X4 
matrix transducer was used for RT3DE guidance. Defect closure was accomplished with 
an originally designed catheter-based patch delivery system. We used various patch 
materials such as Dacron, Gore-Tex, and bovine pericardium. The patch was ﬁxed around 
the defect with Nitinol tissue anchors
Results: RT3DE allowed sufﬁciently detailed visualization of the anatomical structures 
and instruments for safe navigation throughout the procedure. The patches were easily 
deployed. All the anchors were placed securely and penetrated the patch and the atrial 
septum. No surrounding anatomical structures were compromised. Complete closure 
of all the defects was conﬁrmed by Color Doppler echocardiography and post-mortem 
analysis.
Conclusions: Beating-heart ASD closure without cardiopulmonary bypass can be 
successfully achieved using the catheter-based patch delivery system combined with the 
anchor delivery device under RT3DE guidance. This approach can be utilized for any 
ASD geometry and size.
922-112 Sinus of Valsalva Aneurysms-47 Years of Experience
Sherif E. Moustafa, Kenton Zehr, Leslie Cooper, Awil Ali, Farouk Mookadam, Mayo 
Clinic College of Medicine, Rochester, MN, University of Ottawa Heart Institute, Ottawa, 
ON, Canada
Background: Aneurysm of the sinus of Valsalva (SoV) is a rare anomaly that can be 
congenital or acquired. The most common among the acquired is aortic endocarditis.
Methods: The study is a retrospective review that includes all patients who underwent 
SoV aneurysm repair seen at a tertiary US medical center between 1956 and 2003. 
Follow-up ranged from 1 to 40 years with an average of 4 years.
Results: The study identiﬁed 86 patients. Median age was 34.5 (range 5-80) years. 
Approximately half of the patients had associated aortic insufﬁciency. Rupture occurred 
in 50% of the patients. The predominant ﬁstula was a right coronary sinus of Valsalva to 
right ventricle. All of our subjects had SoV aneurysm repair. Sixty-ﬁve (75%) underwent 
associated cardiac procedures. Perioperative mortality was 7%. Actuarial survival at 10 
years was 74.4%. Univariate predictors of late mortality were male gender, associated 
valvular repair and Marfan syndrome (Table).
Conclusions: In the current era, echocardiography is the most frequently used diagnostic 
tool. The most prevalent site of the aneurysm was the right coronary sinus. Additional 
repair of associated VSD, ASD and aortic valve is often required. Marfan syndrome is 
associated with a poor prognosis. Surgical repair confers good long-term survival. 
Perioperative mortality remains high in-patients presenting with rupture. Elective repair 
can be performed with acceptable risk. 
Number of Patients
N(%)
Number of Patients
N(%)
Gender Incidence of Rupture 43(50%)
Male/ Female 54 (62.8%)/32 (37.2%) Site of Rupture
Clinical Presentation Right ventricle 26(30.2%)
Murmur 18(20.9%) Right atrium 14(16.3%)
Dyspnea 18(20.9%) Intraseptal 3(3.5%)
Chest pain 16(18.6%) Surgical Repair 86(100%)
Heart failure 13(15.1%) Combined with aortic valve repair 35(40.7%)
>1 symptom 21(24.5%) Combined with VSD closure 27(31.4%)
Associated Cardiac Defects Combined with ASD closure 3(3.5%)
Aortic insufﬁciency (AI) 38(44.1%) Perioperative Mortality 6(7%)
Ventricular septal defect (VSD) 27(31.4%) % of 10-Year Survival Post Surgery 74.4%
Marfan syndrome 9(10.5%) Male/ Female 50% / 90.6%
Bicuspid aortic valve 8(9.3%) Associated with VSD repair 80%
Atrial septal defect(ASD) 3(3.5%) Associated with ASD repair 76%
Modes of Diagnosis Associated with valve repair 52%
Echocardiography 56(65.1%) Associated with Marfan syndrome 0%
Cardiac catheterization 30(34.9%)
Origin of SoV Aneurysm
Right 60(69.8%)
Non-coronary 23(26.7%)
Left 3(3.5%)
 
922-113 Freedom from Neoaortic Insufﬁciency: A Comparison 
of Classic Norwood and Norwood-Sano Procedures
Sorin V. Pusca, Kirk R. Kanter, Paul M. Kirshbom, Brian E. Kogon, Martha L. Clabby, 
William T. Mahle, Derek A. Fyfe, Emory University School of Medicine, Atlanta, GA, 
Sibley Heart Center Cardiology, Children’s Healthcare of Atlanta, Atlanta, GA
Objectives: Neoaortic valve insufﬁciency (NeoAI) after Norwood palliation of Hypoplastic 
Left Heart Syndrome (HLHS) is infrequent, but it may lead to right ventricular dysfunction. 
The Sano modiﬁcation (right ventricular to pulmonary artery conduit) requires a 
subpulmonary ventricular conduit that may potentialy distort the neoaortic valve. The 
incidence of NeoAI after this procedure is unknown. We investigated its incidence after 
Norwood-Sano and compared it to the classic Norwood.
Methods: We analyzed the echocardiograms of 59 consecutive patients who survived a 
minimum of 3 months with HLHS(deﬁned as left ventricular and aortic and mitral severe 
hypoplasia or atresia). NeoAI was categorized as absent or mild<1mm jet, moderate 1-
3mm jet, or severe>3mm jet . The patients were grouped according to initial palliation: 
classic Norwood and Norwood-Sano operation. Results were reviewed up to the most 
recent echocardiogram (table).
Results: NeoAI was absent or mild in 55 of 59 (93.22 %) of the patients (table 1). There 
were 4 cases of signiﬁcant NeoAI at late followup: 2 moderate in classic Norwood and one 
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922-109 Pulmonary Autograft Dilatation After Ross Procedure: 
Incidence of and Risk Factors
Mark Ruzmetov, Mark D. Rodefeld, Palaniswamy Vijay, Mark W. Turrentine, John W. 
Brown, Indiana University School of Medicine, Indianapolis, IN
BACKGROUND: The Ross procedure is an alternative to mechanical aortic valve 
replacement (AVR) in the young. Early dilatation of the pulmonary autograft root exposed 
to the systemic circulation has been reported. The aim of our study is to deﬁne the 
prevalence of risk factors for, and consequences of late autograft dilatation, outcome in 
all consecutive patients who underwent Ross procedure in our Institution.
METHODS: Between June 1993 and June 2005, 167 patients (mean age 24.9+15.5years; 
range, 1 month to 61 years) underwent Ross AVR: 48% were less than 19 years old. 
Seventy-eight additional procedures were performed in 55 patients (33%) at the time of 
the Ross procedure. End-points of the study were freedom from autograft dilatation (root 
diameter >4cm), from (moderate) autograft regurgitation and from reoperation.
RESULTS: There were 2 early (1.2%) and one late deaths (0.6%) over a mean follow-
up of 5.1+3.0 years (range; 1 month to 12 years). Actuarial survival at 10 years was 
98%. Late autograft dilatation was identiﬁed in 31 patients (19%) and regurgitation in 
12 (7%), all of whom had autograft dilatation. At 10 years, freedom from dilatation was 
81%, freedom from regurgitation was 92%, and freedom from reoperation was 96%. Cox 
proportional hazard analysis identiﬁed preoperative aortic annulus dilatation (p=0.004), 
root replacement technique (p=0.001), younger age (p=0.05), time of surgery (p=0.002), 
and male sex (p=0.01) as predictive of autograft dilatation, whereas ascending aorta 
diameter (p=0.01), male sex (p=0.03), and postoperative systemic pressure (p=0.05) as 
predictive of autograft regurgitation.
CONCLUSION: Autograft dilatation is common late after the Ross procedure, particularly 
in younger male patients, in those with preoperative aortic aneurysm, and those having 
root replacement without support of annulus and sinotubular junction. Signiﬁcant autograft 
dysfunction affects a minority of patients, but it is more prevalent in those with autograft 
dilatation.
922-110 Long-Term Outcomes of Patients With Tricuspid Atresia 
With Transposition or Normally Related Great Arteries
Luca Trento, Ruey-Kang Chang, YT Lan, Vidya Narayan, Hillel Laks, David Geffen 
School of Medicine at UCLA, Los Angeles, CA
Background: Tricuspid atresia is the most common single ventricle congenital heart 
disease often requiring a Fontan operation to achieve long-term palliation. The relationship 
of the great arteries may play an important role in determining the treatment strategies 
and long-term outcomes.
Methods: We reviewed a single institution experience from 1980-2004 of 205 consecutive 
patients with a diagnosis of tricuspid atresia with d-transposed great arteries (TA-TGA) or 
normally related great arteries (TA-NRGA). Data were obtained from the patient’s medical 
record, and the referring physician was contacted to determine the current status of the 
patient. Patients who were lost to follow-up (n = 29) were excluded.
Results: There were 176 patients with median follow up of 10.6 years (ranging 0.03 to 
48.62 years), including 138 patients (78%) with TA-NRGA and 38 patients (22%) with 
TA-TGA. There was a male predominance in TA-TGA, compared with TA-NRGA (74% 
vs. 49%, p = 0.01). Pulmonary atresia or pulmonary stenosis was more common in 
patients with TA-NRGA (p = 0.01). There was no signiﬁcant difference in the incidence of 
arrhythmia or pacemaker requirement between the two groups. The overall mortality rate, 
including death or need for orthotopic heart transplantation was 31%. The overall mortality 
in TA-NRGA was signiﬁcantly lower than TA-TGA (27% vs. 47%, p = 0.03). Kaplan-Meier 
curves showed 1, 5 and 20 year survival rates for TA-NRGA were 93%, 89% and 75%, 
whereas for TA-TGA were 76%, 65% and 43%. 68% of the patients underwent the Fontan 
operation. Post-Fontan mortality was 24%, and was lower for patients staged with a 
Glenn shunt (11% vs. 33%, p = 0.01). Neither pre-Fontan hemodynamics nor age at 
Fontan operation were predictors for post-Fontan mortality. Survival following the Fontan 
operation was 85% at 10 years, but dropped to 30% by 20 years.
Conclusions: Great artery relation in patients with tricuspid atresia has signiﬁcant 
treatment and prognostic implications. The greatest difference in survival between TA-
TGA and TA-NRGA occurs in the ﬁrst year. Although the majority of patients achieved 
Fontan palliation, late mortality between 10-20 years is very high.
922-111 Real-Time Three-Dimensional Echocardiography-guided 
Beating-heart Atrial Septal Defect Closure: The Next 
Step Toward Hybrid Procedures
Nikolay V. Vasilyev, Yoshihiro Suematsu, Joseph F. Martinez, Franz P. Freudenthal, 
Gerald R. Marx, Ingeborg Friehs, Ivan S. Salgo, Pedro J. del Nido, Children’s Hospital 
Boston, Harvard Medical School, Boston, MA
Background: Current management of atrial septal defect (ASD) by catheter-based device 
deploying techniques has been limited by speciﬁc geometry and size of the defects. Real-
time 3D echocardiography (RT3DE) has been utilized primarily for diagnostic imaging 
but has the potential for guiding beating-heart procedures. We sought to develop the 
catheter-based technique which would be applicable to any type of ASD and to determine 
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moderate, one severe in Norwood-Sano (one requiring valve replacement).All patients 
were initially operated in the ﬁrst week of life.
Conclusion: In patients with HLHS, the Sano modiﬁcation does not appear to be 
associated with an increased incidence of signiﬁcant NeoAI. When present, moderate/
severe NeoAI appeared late and was associated with recurrent ascending aortic or aortic 
arch pathology.
Incidence of moderate or severe NeoAortic InsufﬁciencyMedian follow-up = 
20 months, range 3-66 months
Variable
Classic 
Norwood
Norwood-
Sano
P value
Neo-aortic insufﬁciency after 
stage I
0/29 (0%) 1/30 (3.3 %)
0.33 
(ANOVA)
Neo-aortic insufﬁciency at stage II 
(Glenn)
2/28 (7.2 %) 1/27 (3.7 %)
0.58 
(ANOVA)
Neo-aortic insufﬁciency at stage III 
(Fontan)
0/24 (0%) 2/10 (20 %)
1.000 
(Fisher’s)
Neo-aortic insufﬁciency after any stage 2*/29 (6.7%) 2*/30 (6.7%)
1.000 
(ANOVA)
*In 3 out of 4 cases signiﬁcant postoperative Neo AI appeared after ascending aortic or 
aortic arch patch re-enlargement for stenosis or development of aortic recoarctation.
922-114 Right Ventricle to Pulmonary Artery Shunt Versus 
Modiﬁed Blalock-Taussig Shunt in Hypoplastic Left 
Heart Syndrome: Assessment and Outcome Through 
Stage 2 Palliation
Eric M. Graham, Andrew M. Atz, Scott M. Bradley, Mark A. Scheurer, Varsha M. 
Bandisode, Antonio Laudito, Girish S. Shirali, Medical University of South Carolina, 
Charleston, SC
Background: A recent modiﬁcation to the Norwood procedure involving a right ventricle to 
pulmonary artery shunt (RV-PA) may improve postoperative hemodynamics. Concerns remain 
about a ventriculotomy and its effects on ventricular and tricuspid valve function, as well as 
pulmonary artery growth, candidacy for and outcome following second stage palliation.
Methods: We compared all 53 patients with hypoplastic left heart syndrome who 
underwent the Norwood procedure with a modiﬁed Blalock-Taussig shunt (mBT, n=33) 
versus a RV-PA (n=20). Patient courses were reviewed for post-operative morbidity 
and mortality following the Norwood procedure, interstage mortality, candidacy for and 
outcome following stage 2 palliation. Echocardiograms prior to stage 2 palliation were 
reviewed by a blinded observer. RV function was qualitatively graded in 5 planes from 1 
(normal) to 4 (severely depressed). The average of all 5 planes was used for comparisons. 
Tricuspid regurgitation severity was graded from 1 (none) to 4 (severe).
Results: 
mBT
(n=33)
RV-PA
(n=20)
P value
Norwood mortality and morbidity
Shunt revision 3 (9%) 3 (15%) 0.66
Need for extracorporeal membrane oxygenator 2 (6%) 0 0.52
Hospital death 6 (18%) 2 (10%) 0.70
Pre-stage 2 assessment (n=27) (n=15)
Interstage mortality 5 0 0.14
Echocardiography (n=33) (n=17)
Age (months) 4.9 ±2.7 5.0 ±2.1 0.85
Right ventricular function 1.2 (1-3.1) 1 (1-2.2) 0.10
Tricuspid regurgitation severity 2 (1-4) 2 (1-4) 0.73
TR jet width / tricuspid annulus diameter 0.1 (0-0.4) 0.1 (0-0.5) 0.64
Cardiac catheterization (n=22) (n=14)
Age (months) 5.4 ±1.3 4.8 ±0.8 0.07
Nakata index (mm2/m2) 173 ±56 223 ±84 0.04
Arterial diastolic blood pressure (mmHg) 40 ±6 47 ±7 0.008
Ventricular end diastolic pressure (mmHg) 11 ±2 8 ±2 0.003
Stage 2 palliation (n=22) (n=14)
Age (months) 6.7 ±1.3 6.3 ±1.5 0.40
Hospital death 0 0 1.00
Mechanical ventilator requirement (days) 2.1 ±2.2 1.7 ±2.4 0.64
Intensive care requirement (days) 3.9 ±2.4 4.1 ±3.7 0.83
Hospital length of stay (days) 8.5 ±4.4 9.1 ±6.6 0.77
Fifteen of 17 patients (88%) who underwent a RV-PA survived to stage 2 palliation, 
compared to 22 of 33 patients (67%) who underwent an mBT (p=0.17).
Conclusion: The RV-PA shunt is associated with improved RV function, larger pulmonary 
artery size and higher systemic diastolic pressure. A trend towards improved survival to 
stage 2 palliation was seen following the RV-PA shunt. A larger number of patients may 
reveal statistically signiﬁcant differences between the two approaches.
922-115 A Novel Microaxial Venous Assist Device for Enhancing 
Pulmonary Flow and Reducing Venous Pressure Within 
the Total Cavopulmonary Connection: Computational 
Fluid Dynamics Studies
Rui Wang, Kendall Hunter, Jean Hertzberg, Francois G. Lacour-Gayet, Robin Shandas, 
University of Colorado, Boulder, CO, The Children’s Hospital, Denver, CO
Background: The absence of the right ventricle (RV) predisposes post-Fontan patients 
to poor hemodynamic outcomes due to increased venous pressures and decreased 
pulmonary ﬂow. To overcome this, we propose a novel venous assist device for inferior 
vena cava (IVC) implantation in a total cavopulmonary connection (TCPC).
Methods: Our unique design endpoints were: 15 mm Hg increase across the pump; 
minimal hemolysis- and thrombus-inducing conditions; minimal pressure increase 
at the superior vena cava (SVC); maintenance of some blood ﬂow at pump failure. 
Three-dimensional computational ﬂuid dynamics (CFD) analysis was used to evaluate 
hemodynamics within a model TCPC.
Results: The end design was a microaxial pump, 25 mm in length, 9.5 mm in diameter, 
with magnetically levitated rotor. At an optimal operational point of 6667 RPM and 1.2 
L/min cardiac output, pressure boost of 14 mm Hg was produced (Figure). Active proximal 
suction and constant pressure increase in the face of varying pulmonary vascular 
resistances are unique features. SVC pressure varied minimally (< 10%) for a range 
of operating conditions. Perfusion into the right lung was around 23% of the IVC ﬂow 
ensuring good mixing into both lungs. Blood cells moved through the pump in 10 ms, with 
a maximum shear stress value of 5423 dyne/cm2 at the rotor’s leading edge, indicating 
minimal hemolysis.
Conclusions: This microaxial venous assist device appears promising for alleviating the 
downward spiral of hemodynamic incompetence in TCPC patients.
922-116 The RV to PA Conduit in the Modiﬁed Norwood 
Procedure: A Caveat
Zohair Y. Al-Halees, Ahmad Sallehuddin, Muhammed Tamim, Mamdouh Al Ahmadi, 
Ahmed Al Omrani, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi 
Arabia
BACKGROUND: We sought to deﬁne effect of introducing Sano right ventricle (RV) to 
pulmonary artery (PA) shunt at time of Norwood procedure on second stage palliation 
(bidirectional Glenn).
METHODS: 1996-June 2005, 86 patients (pts) underwent Norwood procedure. Mean 
age 30 days (range 2-150), mean weight 3.1-kg (range 2-4.3kg). Excluded patients with 
signiﬁcant pulmonary or tricuspid regurgitation, impaired RV function, chromosomal 
abnormalities, social reasons. Modiﬁed Blalock-Taussig shunt was source of pulmonary 
blood. In 2002, Sano shunt was introduced (5 or 6mm Goretex). Impact of this on 
survival and second stage palliation [particularly pulmonary vascular disease (PVD)] was 
evaluated. Lung biopsies obtained from 11-patients at time of Glenn.
RESULTS: Overall hospital mortality 30% (11% last 2 years). Positive impact of Sano 
shunt was noted on mortality and ICU care, but ICU stay unchanged (average 12 days). 
Four patients lost to follow, one had a biventricular repair, 2 interim deaths, 38 bidirectional 
Glenn (2 early, 1 late deaths), 18 completed Fontan (1 death). Cardiac Cath before Glenn 
demonstrated tendency towards elevated pulmonary vascular resistance in Sano shunt 
group. Lung biopsies showed pulmonary vascular changes: grade 0-1pt, grade I-4, grade 
II-3, grade III-2, grade IV-1. Early biopsy results prompted a policy change towards earlier 
Glenn (at 3-4months instead of 6). With early Glenn, PVD was only grade 0 or I.
CONCLUSION: Use of Sano shunt in Norwood procedure improved hospital mortality 
and simpliﬁed ICU care. However, this might be associated with earlier development of 
PVD. Patients, therefore, many need and earlier second stage palliation.
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945-109 PFO Closure With the Amplatzer, CardioSEAL-STARﬂex 
and Helex Occluder: A Randomized Trial
Margaret Taaffe, Evelyn Fischer, Leetz Michaela, Nico Majunke, Corinna Heinisch, 
Andreas Baranowski, Ralph Hein, Franziska Büscheck, Yves Bayard, Madlen Reschke, 
Horst Sievert, CardioVascular Center Frankfurt, Frankfurt, Germany
Background: The Amplatzer- (A), Helex- (H) and the CardioSEAL-STARﬂex (C) Occluder 
are three of the most commonly used devices in percutaneous closure of PFO.
Methods: Between January 2001 and December 2004 catheter PFO closure with the 
devices was attempted in 660 patients (361 men, 299 women, mean age 49.34 ± 1.9 yrs) 
as part of a randomized trial. PFO closure was indicated due to a history of paradoxical 
embolism, migraine and/or decompression illness. The patients were randomized 
with 220 patients in each group with no signiﬁcant differences regarding the baseline 
characteristics.
Results: The mean PFO size was 9.7±3.7mm in the Amplatzer group, 9.3±3.8mm in the 
Helex group and 9.5±3.6mm in the CardioSEAL-Starﬂex group and ranged from 2-26 
mm. All PFO closures were technically successful. Seven of the Helex Occluders were 
retrieved before release and exchanged for another Helex due to an unsatisfactory position. 
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During the procedure one patient (with a CardioSEAL-Starﬂex Occluder) experienced an 
episode of atrial ﬁbrillation without sequalae. Two Helex-Occluders embolized and were 
retrieved successfully. Five Amplatzer patients received an Amplatzer ASD-Occluder 
as the defect was too large. One Helex patient received an Amplatzer-Occluder for 
technical reasons. Complications before discharge included one patient in the Amplatzer 
group who developed a tamponade and had to undergo surgery. A Helex patient had a 
TIA immediately after implant with no need for treatment. One additional Helex device 
embolized after implant and was replaced by another Helex occluder . Within 30 days of 
implant eight patients (all in the (C) group) developed a thrombus which resolved after 
anticoagulation treatment. The patients remained asymptomatic. Fifteen patients suffered 
from episodes of atrial ﬁbrillation, ten were of the (C) group, two of the (H) and three of 
the (A) group.
Conclusions: PFO-closure can safely be performed with all three devices. However, 
periprocedural and within 30 days, the Helex-Occluder more frequently embolized and 
the CardioSEAL-Starﬂex-Occluder more frequently led to thrombus formation on the 
device and paroxysmal atrial ﬁbrillation.
945-110 Cribier-Edwards™ Aortic Bioprosthesis in the Pulmonic 
Position; Initial Animal Experience
Francisco Garay, Qi-Ling Cao, Jane Olin, Helene Eltchaninoff, Deborah Nercolini, Ziyad 
M. Hijazi, University of Chicago Hospitals, Chicago, IL, Hospital Charles Nicolle, Rouen, 
France
Currently, for pulmonary insufﬁciency (PI), only one valve (Bonhoeffer-Medtronic) has 
been tested and evaluated in humans. We report our initial animal experience with the 
Cribier- Edwards™ Aortic Bioprosthesis (PHV: Percutaneous Heart Valve) in the pulmonic 
position. The PHV is made of equine pericardial leaﬂets sewn inside a stainless steel 
stent and is available in two sizes 23 and 26 mm that require a 22 and 24 Fr sheaths 
respectively for delivery. Acute animal testing was performed on a total of 3 pigs and 3 
sheep (35 - 40 kg). In 2 sheep the PHV was positioned at the site of the native pulmonic 
valve, however the PHVs migrated due to the small size (23 mm. In the three pigs, 
implantation covered the native pulmonic valve. In 2 pigs the PHV migrated because 
the native pulmonic valve was too distensible for the 23mm PHV. In 1 pig, the PHV was 
implanted in a 16mm native pulmonic valve with good function and mild angiographic PI 
due to the presence of a catheter through the leaﬂets.
Chronic animal model consisted of two protocols. Protocol one: The PHV was implanted 
percutaneously into the pulmonary artery (PA) via the jugular vein in 10 animals with 5 
survivors to 20 weeks with good valve function at explant. At this time all of the 20-week 
valves have been explanted and are undergoing histological examination. Protocol 2: the 
PHV was implanted via a jugular vein cut-down into a pulmonary conduit (Edwards Prima 
Plus™) that was surgically constructed in 4 sheep (40-50 kg). The native pulmonary 
valves of the animals were partially destroyed. Three animals survived the implantation 
to 20 weeks. Immediate angiography revealed mild regurgitation. At 20 weeks, only one 
valve was competent and free of calcium deposits. On the other two animals, the original 
valves were found to be still functioning and thus there was insufﬁcient backﬂow pressure 
to close the PHV.
The percutaneously implanted Edwards pulmonic valve functions well under pulmonary 
pressure and can be delivered from femoral or jugular vein access. Acute and early 
chronic (20 weeks) animal studies are encouraging. Future steps are to complete the 
chronic animal studies, optimize the delivery system and perform pulmonary replacement 
in clinical cases.
945-111 Outcomes of Stent Implantation for Native and 
Recurrent Coarctation of the Aorta (COA): 
Classiﬁcation and Implications of Aortic Wall Injury
Athar M. Qureshi, Audrey C. Marshall, Doff B. McElhinney, Michael J. Landzberg, Peter 
Lang, James E. Lock, Children’s Hospital Boston, Harvard Medical School, Boston, MA
Background: Short-term outcomes of COA stenting have been documented, but 
intermediate-term data regarding the efﬁcacy and safety of COA stenting are lacking. The 
purpose of this study was to assess a new method for describing aortic wall injury and to 
review our experience of aortic stenting.
Methods: Data from patients (pts) who underwent implantation of endovascular stents in 
the aorta between 12/89 and 7/05 were reviewed. Aortic wall injuries were categorized as 
therapeutic tears, dissections, aneurysms, or ruptures.
Results: A total of 171 pts underwent aortic stent implantation at a median age of 15 yrs 
(5 days to 61 yrs): 68 (40%) pts had native COA, 17 (10%) had single ventricle circulation, 
and 17 (10%) had an arteriopathy. The target lesion was predilated in 138 pts (81%). The 
mean minimal lesion diameter increased from 8.4±3.5 to 13.9±4.1mm (p<0.001) and the 
median peak systolic gradient decreased from 30(4-130) to 2(0-60) mmHg (p<0.001). 
Acute aortic wall injuries other than therapeutic tears were observed in 4 pts (2.3%): 1 
dissection, 2 aneurysms, 1 rupture. In 3 of these pts, the intention was to perform balloon 
dilation alone, but a stent was placed to stabilize the aortic wall injury. Follow-up data were 
available in 162 pts (95%), a median of 2.6 yrs (2 mo to 13 yrs) after stent placement. 
There were 4 deaths unrelated to stent implantation. Reintervention was performed in 58 
pts, (surgery 5, catheter-based 53). Freedom from reintervention was 81% at 1 yr, 47% 
at 5 yrs, and 44% at 10 yrs. Adverse events related to reintervention occurred in 3 pts, 
including aortic rupture in 2. Follow-up aortic imaging was performed in 94 pts a median of 
2.8 yrs after stent placement (angiography 62, CT/MRI 23, angiography plus CT/MRI 16). 
New aneurysms were observed on follow-up imaging in 6 of 94 pts, (6%).
Conclusions: Acute hemodynamic results of stenting for COA and other forms of aortic 
obstruction are encouraging. Serious aortic wall injuries are uncommon in our experience, 
and can be minimized with a focus on technical measures, such as predilation before 
stenting. Better understanding of the mechanisms and signiﬁcance of aortic wall injury is 
needed and will require further study.
945-112 Bare Stenting of Obstructed Right Ventricle-to-
Pulmonary Artery Conduits: A Fifteen-Year Experience
Lynn F. Peng, Doff B. McElhinney, Alan W. Nugent, Andrew J. Powell, Audrey C. 
Marshall, Emile A. Bacha, James E. Lock, Children’s Hospital Boston, Boston, MA
Background: The optimal timing and method of treatment for dysfunctional right 
ventricle-to-pulmonary artery (RV-PA) conduits in patients (pts) with congenital heart 
disease is unknown.
Methods: Pts with placement of one or more stents in a pulmonary outﬂow conduit over 
a 15-year (yr) period were identiﬁed.
Results: Between 1990 and 2004, balloon-expandable bare stents were deployed in 243 
obstructed RV-PA conduits in 225 pts, at a median age of 6.7 yrs. A total of 271 Palmaz 
stents were placed.
After stenting, RV systolic pressure decreased from 89±18 to 65±20mmHg and the 
peak RV-PA gradient decreased from 59±19 to 27±14mmHg (p<0.001). Five procedures 
(2.1%) were complicated by stent malposition requiring surgical removal. There were no 
deaths or other signiﬁcant procedural complications.
During follow-up of 3.9±3.3 yrs, 10 pts died or underwent heart transplant, none related 
to catheterization or stent malfunction. 147 follow-up catheterizations were performed 
in 122 pts, with dilation of the conduit stent in 81 and additional stent placement in 39. 
Stent fractures were diagnosed in 53 pts (43%), and were signiﬁcantly associated with 
stent compression at the time of implantation and substernal location. Stent fragments 
embolized to the RV or PA in 13 pts. Stent fracture did not contribute to death or acute 
hemodynamic consequences.
Conduit reoperation was performed in 138 pts. By Kaplan-Meier analysis, the median 
freedom from conduit surgery was 2.7 yrs (3.8 yrs in pts > 5 yrs), with signiﬁcantly shorter 
freedom from reintervention in younger pts, those with higher post-stent RV pressure, 
and those with diagnosis other than tetralogy of Fallot. Tricuspid regurgitation and RV 
function did not worsen but did not improve in the interval between stent implantation and 
subsequent surgery.
Conclusions:  Conduit stenting is an effective interim treatment for RV-PA conduit 
obstruction and prolongs conduit lifespan in most pts. Stent fractures did not lead to 
signiﬁcant complications and were not associated with earlier conduit reoperation.
945-113 Atrial Septostomy Improves Survival in Primary 
Pulmonary Hypertension and Pulmonary Hypertension 
with Associated Congenital Heart Disease
Mark A. Law, Ronald G. Grifka, Charles E. Mullins, Michael R. Nihill, Texas Childrens 
Hospital, Houston, TX
Background: As a bridge to lung transplant, atrial septostomy is a palliative option for 
patients with pulmonary hypertension (PHTN) refractory to vasodilator therapy. Atrial 
septostomy can improve hemodynamic parameters correlating with increased survival; 
however, it carries a risk of morbidity and mortality.
Methods: We performed a retrospective analysis of patients with PHTN who underwent 
an atrial septostomy at our institution over the past 24 years.
Results: Forty-six atrial septostomy procedures were performed on 43 patients. Patient 
age ranged from 0.12 to 30 years (median = 12.5). 26/43 patients had primary PHTN, 
12/43 had PHTN associated with a repaired congenital heart defect, and 5/43 had 
persistent PHTN of the newborn or a collagen vascular disease. Mean PVR = 34 ± 17 
Wood units, and mean PA pressure = 72 ± 20 mmHg. Patients surviving greater than 30 
days had signiﬁcant hemodynamic improvement in cardiac index (2.3 to 2.9 L/min/m2, 
p<0.001), right atrial pressure (9.8 to 8.3 mmHg, p<0.05), and oxygen delivery (424 to 
491 ml O2/min, p<0.01) even with a decrease in systemic saturation of 7% (94 to 87%, 
p<0.001). PA pressure was unchanged (p=ns). NYHA class improved from 3.3 to 2.7 
(p<0.01). Event free survival at 1, 2, and 3 years was 84%, 77%, and 69%, respectively. 
Using the NIH Registry model, their predicted survival probability signiﬁcantly improved 
from 66%�73%, 53%�62%, 42%�52% at 1, 2, and 3 years, respectively (p<0.001). 
Ten patients (22%) died within 30 days of catheterization. Mortality was associated with 
a preceding decompensation in the pediatric intensive care unit (6/10, p<0.001) and 
signiﬁcantly higher right atrial pressures (21.4 vs 9.8 mmHg, p<0.001).
Conclusions: Atrial septostomy provides symptomatic and hemodynamic improvement 
in cardiac index and right atrial pressure, parameters that are known predictors of 
survival. Septostomy should not be performed as rescue therapy in patients with 
preceding decompensation. Furthermore, septostomy should be approached with caution 
in patients with a right atrial pressure greater than 20 mmHg.
945-114 Percutaneous Pulmonary Valve Implantation: A Cost-
Effective Strategy for Management of Right Ventricular 
Outﬂow Tract Dysfunction
L. Coats, F. Sun, J. E. Deanﬁeld, P. Mcginley, P. Bonhoeffer, Andrew Mcguire, Great 
Ormond Street Hospital for Children, London, United Kingdom, London School of 
Economics, London, United Kingdom
Background Percutaneous pulmonary valve implantation (PPVI) is a new alternative to 
surgical valve replacement (PVR) for suitable patients with right ventricular outﬂow tract 
dysfunction.
Method We compared models of cost and cost-effectiveness over 25 years for PPVI, based 
on data of 84 patients, against known costs and outcomes for PVR in 94 contemporary 
patients together with long-term projections from literature and assumption. Costs 
included the initial procedure, subsequent complications and re-operations. Outcome was 
measured by life expectancy. Sensitivity analysis was used to determine the implications 
of varying valve price or re-intervention rate in the PPVI group.
Results PPVI had less hospital stay, fewer complications and lower mortality. As a result, 
despite a higher re-operation rate, PPVI was more cost-effective at all time points than 
surgery. Cost per additional life year gained after PPVI was approximately $2000. The 
PPVI device would need to be greater than $20 000 to exceed surgical costs over 25 years. 
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Furthermore, assuming all late explantations (>5 years) could be treated percutaneously, 
the repeat PPVI rate could be 17% per year before this approach becomes less cost-
effective than surgery.
Conclusion Based on current data, PPVI appears a cost-effective option compared to 
PVR in the short and long term. Longevity of the percutaneous valve does not need to 
match that of surgically implanted valves to retain cost-effectiveness.
945-115 Assessment of the Markers of Platelet and Coagulation 
Activation Following Transcatheter Closure of Patent 
Foramen Ovale in Patients with Cryptogenic Stroke
Elizabeth Bedard, Josep Rodés-Cabau, Christine Houde, Ariane Mackey, Donald 
Rivest, Kathleen Raby, Martin Noel, Jean Marc Côté, Alier Marrero, Marie Helene 
Leblanc, Philippe Chetaille, Olivier F. Bertrand, Stephanie Cloutier, Quebec Heart 
Institute - Laval Hospital, Quebec, PQ, Canada, Centre Hospitalier Universitaire Laval, 
Quebec, PQ, Canada
Background: To date no biological or clinical studies have evaluated the most adequate 
antithrombotic treatment (antiplatelet vs anticoagulant) following transcatheter closure of 
patent foramen ovale (PFO) in patients with cryptogenic stroke. However, dual antiplatelet 
treatment (clopidogrel in addition to aspirin) is increasingly used in such cases. The 
objective of this study was to prospectively evaluate the presence, degree and timing of 
the activation of platelet and coagulation systems following transcatheter closure of PFO 
in patients with cryptogenic stroke.
Methods: Fourteen consecutive patients (mean age 42±11 years, 6 males) with previous 
cryptogenic stroke who underwent successful transcatheter closure of PFO with the 
Amplatzer PFO occluder were included in the study. The median time between the stroke 
and PFO closure was 4 months (3-24 months) and all patients were treated with aspirin 
325 mg/day. Prothrombin fragment 1+2 (F1+2) and thrombin-antithrombin III (TAT) were 
used as markers of coagulation activation, and soluble P-selectin (sP-selectin) and 
soluble CD40 ligand (sCD40L) as markers of platelet activation. Measurements of all 
hemostatic markers were taken at baseline just before the procedure, and at 7, 30 and 90 
days following device implantation.
Results: F1+2 and TAT levels increased from 0.43±0.12 ng/mL and 1.9±0.81 ng/mL at 
baseline, to a maximal value of 0.65±0.16 ng/mL and 4.8 ±2.2 ng/mL at 7 days, respectively, 
gradually returning to the baseline levels at 90 days (P<0.0001 for both markers). Levels 
of sP-selectin (baseline 32±22 ng/mL) did not change at any time following PFO closure, 
and sCD40L levels decreased at 7 days (723±585 pg/mL vs 280±192 pg/mL) and 
remained lower than baseline at 90 days (320± 290 pg/mL) (P=0.03).
Conclusions: Transcatheter closure of PFO is associated with a signiﬁcant activation 
of the coagulation system with no increase in the markers of platelet activation. These 
ﬁndings would favour short-term anticoagulation as antithrombotic treatment following 
PFO closure in patients with cryptogenic stroke and provide no biological basis for dual 
antiplatelet therapy (clopidogrel in addition to aspirin) in these cases.
945-116 Regression of Severe Infundibular Stenosis and Severe 
Tricuspid Regurgitation After Pulmonary Balloon 
Valvuloplasty Long-Term (Up to 17-Years) Outcome of 
Pulmonary Balloon Valvuloplasty in Adults
Mohamed Eid Fawzy, Hani Al Sergani, Fayez El Shaer, Mohammed Monsour, Adil 
Osman, Charles C. Canver, King Faisal Heart Institute, Riyadh, Saudi Arabia
Background: Signiﬁcant infundibular stenosis and signiﬁcant tricuspid regurgitation (TR) 
occasionally result from severe pulmonary valve stenosis (PS) in adults, and these 
two conditions have an adverse impact on morbidity and mortality if patients undergo 
surgery.
Objectives: The aim of the study was (1) to evaluate the long-term outcome of pulmonary 
balloon valvuloplasty (PBV) in adults (2) to evaluate the effect of successful PBV on 
severe infundibular stenosis and severe TR.
Methods: PBV was performed in 90 patients (49 females, 41 males) mean age 23 ±9; 
(range: 15-54) years with congenital pulmonary valve stenosis. Clinical and Doppler 
echocardiography follow-up was performed for 2 - 17 (mean 10 ± 3.9) years after PBV 
repeat cardiac catheterization was performed in 53 patients 1-2 years after PBV.
Results: There were no immediate or late deaths. The mean catheter peak pulmonary 
gradient (PG) before and immediately after PBV, and at intermediate follow-up was 
105 ± 3, 34 ± 26 (p <0.0001) and 17 ± 14 (p < 0.0001) mm Hg, respectively. The 
corresponding values for right ventricular pressure were 125 ± 38, 59 ± 21 (p <0.0001) 
and 42 ± 12 (p <0001) mm Hg, respectively. The infundibular gradient immediately 
after PBV was 31 ± 23 mm Hg and it regressed at intermediate follow-up to 14 ± 9 mm 
Hg (p < 0.0001), whilst cardiac index improved from 2.68 ± 0.73 to 3.1 ± 0.4 l/min/m2 
(p < 0.05) at intermediate follow up. Doppler PG before PBV and at intermediate and 
long-term follow-up were 91 ± 33 (range 36 - 200) mm Hg, 28 ± 12 (range 10-60) 
mm Hg (p < 0.0001) and 26 ± 11 mm Hg (p = 0.2), respectively. New mild pulmonary 
regurgitation (PR) was noted in 24 patients (25%) after PBV. Signiﬁcant TR in seven 
patients regressed or disappeared after PBV.
Conclusion: 1) Long-term results of PBV in adults are excellent. 2) Severe infundibular 
stenosis and severe TR regressed after successful PBV. Hence, PBV should be 
considered as the treatment of choice for adult patients with PS even in the presence of 
severe infundibular stenosis or severe TR.
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967-109 B-Natriuretic Peptide Levels Are Elevated in Single 
Ventricle Patients With Systemic Ventricular Failure but 
not With Cavopulmonary Failure
Yuk M. Law, Lee Beerman, Stevan Tofovic, Jose Ettedgui, Oregon Health & Science 
University, Portland, OR
Background: The pathophysiology of heart failure (HF) in single ventricle (SV) circulation 
may be distinct from that of cardiomyopathies. We hypothesize that BNP is elevated only 
if HF involves the systemic ventricle but not in isolated Glenn/Fontan or cavopulmonary 
(CP) failure as BNP secretion is dependent on myocardial wall stress.
Methods: BNP levels were measured consecutively in SV patients at catheterization 
(n=22; 7 normal controls) and when assessing for HF (11).
Results: Of 33 SV subjects (median age 62 mos), 13 had aortopulmonary and 20 CP 
shunts (Glenn=6, Fontan=14). Median/mean +/-SEM BNP levels by shunt type were 
184/754 +/-301 pg/mL in aortopulmonary, 38/169+/-56 in CP, and 10/11+/-2 in control group 
(median age 185 months, p=.004, Kruskal Wallis test). Of all hemodynamic parameters, 
only systemic ventricular end-diastolic pressure, mean 9.4+/-0.8 mmHg (median=8), 
correlated with BNP (Spearman R=0.5, p=.034). The group with symptomatic HF from 
abnormal systemic ventricular loading conditions or dysfunction had median/mean BNP 
of 378/714+/-215 (n=18) vs. isolated failed Fontan/Glenn 19/23+/-6 (n=7, p=.001), and 
vs. no HF 22/22+/-4 (n=8, p=.001, Mann-Whitney test). All 7 of these isolated failed CP 
subjects (6 with failed Fontan) were hospitalized for symptomatic decompensated HF: all 
had normal systolic function, on parenteral diuretics, 4 on inotropes, and 4 on the ventilator. 
Excluding these failed CP subjects, median/mean BNP levels were also associated with 
severity of HF in SV patients: with 1 HF identiﬁer, median/mean BNP’s were 18/71+/-56 
(n=3), with 2 HF identiﬁers 544/643+/-244 (10), > 3 identiﬁers 839/1241+/-552 (5), and no 
HF 22/22+/-4 (8, p<.001, Kruskal Wallis test).
Conclusions: BNP is elevated in SV patients with systemic ventricular side or “left-
heart” failure. Missing a pulmonary ventricle, it is not elevated in patients with isolated 
cavopulmonary or “right-heart” failure. This is a unique physiological ﬁnding in HF and 
adds to our understanding of the SV circulation and the application of BNP testing to the 
congenital heart disease population.
967-110 B-Type Brain Natriuretic Peptide in Preterm Infants With 
Patent Ductus Arteriosus
Ruben J. Acherman, Gabriel Diaz, William N. Evans, Gary A. Mayman, Adriana 
Montealegre, Alicia Marquez, Carlos F. Luna, Abraham Rothman, Kathleen A. Cass, 
Humberto Restrepo, Children’s Heart Center, University of Nevada, School of Medicine, 
Las Vegas, NV, Instituto Materno Infantil, Universidad Nacional de Colombia, Bogota, 
Colombia
BACKGROUND: Brain natriuretic peptide (BNP) is a cardiac hormone released mainly 
by the cardiac ventricles in response to ventricular volume and/or pressure overload. BNP 
has been reported as a useful test in the diagnosis of patent ductus arteriosus (PDA) in 
premature newborns.
OBJECTIVES: To evaluate the usefulness of determination of BNP serum levels in the 
diagnosis of PDA in a group of premature newborns.
METHODS: This study included 29 premature newborns (mean gestational age (GA): 
31.6 ± 2.1 weeks) with PDA. The presence of a PDA was established by echocardiography 
(echo). Serum for BNP levels was collected at the time of echo. Patients were followed 
with serial echo until closure of the ductus was documented. Another blood sample for 
BNP was obtained with the last echo. Patients with heart disease other than PDA were 
not part of the study. BNP levels were also measured in 19 premature newborns without 
PDA (control group with a mean GA 32.0 ± 1.8 weeks and mean post-natal age of 2.7 
±1.4 days). BNP levels were measured using a commercial kit (Triage® BNP Test Biosite 
labs, San Diego CA).
RESULTS: There were 13 males and 16 females. Patients with a PDA had signiﬁcantly 
higher mean BNP levels (858.5 ± 945.6 vs. 105.9 ± 135.4 pg/mL, p = 0.002) than control 
group at age of PDA diagnosis (2.8 ± 1.5 days vs. 2.7 ±1.4 days). There was no correlation 
between BNP levels and PDA diameter, pressure gradient across the PDA, left atrium/
aorta ratio. The area under the receiver operator characteristic (ROC) curve for detection 
of PDA was 84% (95% conﬁdence interval: 72%-95%). BNP level cut-off for diagnosis of 
PDA at 2.8 ± 1.5 days was: 155.5 pg/ml (Sensitivity: 75.9%, Speciﬁcity: 83.3%, Positive 
likelihood ratio: 4.5)
CONCLUSIONS: The BNP test showed highly predictive diagnostic values. BNP levels 
were signiﬁcantly higher in this group of premature infants with PDA.
967-111 Relation Between Plasma Brain Natriuretic Peptide, 
Right Ventricular Function and Exercise Capacity in 
Patients After Surgical Repair of Tetralogy of Fallot
Eddie W Y Cheung, Yiu-fai Cheung, Cardiac Paediatric Unit, Grantham Hospital, Hong 
Kong, Hong Kong
Background: Right ventricular (RV) dysfunction secondary to pulmonary regurgitation is 
a signiﬁcant determinant of exercise capacity in patients after surgical repair of tetralogy 
of Fallot (TOF). Increased plasma brain natriuretic peptide (BNP) level has been proposed 
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as a marker for ventricular dysfunction in adults. We tested the hypothesis that plasma 
BNP level relates to RV function and exercise capacity in children with pulmonary 
regurgitation after TOF repair.
Methods: The plasma BNP levels, M-mode-derived RV end-diastolic dimensions, RV 
myocardial performance index (MPI), severity of pulmonary regurgitation (PR) and 
tricuspid annular velocities were determined in 32 postoperative TOF patients (10 with 
pulmonary atresia), aged 14.2±2.6 years. The results were compared with those obtained 
in 16 age-matched controls (13.1±3.0 years, p=0.2) who had undergone repair of 
ventricular septal defect. Eighteen TOF patients underwent exercise testing.
Results: When compared with controls, patients had signiﬁcantly higher BNP level 
(46.3±85 pg/ml vs 16.6±8.0 pg/ml, p=0.04), greater indexed RV end-diastolic dimension 
(2.47±0.85 cm/m2 vs 1.32±0.35 cm/m2, p<0.001), increased RV MPI (0.29±0.18 vs 
0.16±0.15, p=0.021), and reduced tricuspid annular systolic myocardial velocity (8.9±2.1 
cm/s vs 10.7±2.0 cm/s, p=0.006). In patients, log BNP correlated with indexed RV end-
diastolic dimension (r=0.76, p<0.001) and PR colour jet width/RV outﬂow dimension 
ratio (r=0.37, p=0.04), but not RV MPI or tricuspid annular velocities. Signiﬁcant negative 
correlations were found between log BNP and exercise duration (r=-0.58, p=0.012), peak 
oxygen consumption (r=-0.56, p=0.015), and minute ventilation at maximal exercise 
(r=-0.60, p=0.009). Multivariate analysis demonstrated log BNP (�=-0.65, p=0.002) 
and body mass index (�=-0.50, p=0.012) to be independent predictors of peak oxygen 
consumption after adjustment for age, sex, duration from surgery, RV MPI, and tricuspid 
annular velocities.
Conclusions: The plasma BNP level relates to pulmonary regurgitation, RV dimension 
and exercise capacity in patients after TOF repair.
967-112 Acute Hemodynamic Effects of Right and Left 
Ventricular Pacing in the Normal Heart: Implications for 
Cardiac Pacing in Children
Mark K. Friedberg, Anne M. Dubin, George F. Van Hare, George McDaniel, David N. 
Rosenthal, Stanford University, Palo Alto, CA
Background: Effects of cardiac pacing on ventricular function are important in various 
conditions requiring pacing in children, including cardiac resynchronization. While chronic 
RV apical pacing may compromise cardiac function, acute effects of pacing are poorly 
characterized. We studied acute effects of RV and LV pacing in children with normal 
hearts, evaluating electrical and mechanical synchrony and global function.
Methods: 13 children (12 ± 4 yrs) with normal cardiac structure/function were paced 
after ablation of accessory pathways, at baseline (AOO), and with AV pacing (DOO) 
from the RV apex (RVA), RV outﬂow (RVOT) and LV in random sequence. AV pacing 
interval was 80% of PR interval. We measured QRS duration from surface ECG and 
mechanical synchrony by pulsed tissue Doppler (Q- onset S’ interval) at the mitral, septal 
and tricuspid annulus from a 4 chamber view. Cardiac index (Fick) assessed LV function; 
RV dP/dT (Millar Inc.) assessed RV function. Data were analyzed by ANOVA.
Results: Results are given in the table. Pacing markedly prolonged the QRS, causing 
electro-mechanical dyssynchrony. RVOT pacing caused the most signiﬁcant intra-
ventricular delay in the RV and LV. Intra-ventricular delay did not change blood pressure, 
RV dp/dT, or cardiac index, indicating preserved global biventricular function.
Conclusions:
RVA, RVOT or LV pacing induce electro-mechanical dyssynchrony. Despite marked QRS 
prolongation, global ventricular function remained unchanged. 
Baseline (atrial 
pacing)
RVA 
Pacing
RVOT 
pacing
LV 
pacing
(n=5)
QRS, msec (% change from baseline) 80±20
131±39 *
(164%)
123±32 *
(154%)
136±35 *
(170%)
Change in LV free wall activation time 
(msec)†
0 (baseline value) 23±17 * 29±20 * 23±37
Change in septal activation time (msec) 0 36±19 * 12±23 46±32 *
Change in RV free wall activation time 
(msec)
0 27±18 * 34±19 * 23±18 *
RV intra-ventricular delay (msec) 14±7 12±11 47±30* 19±6
LV Intra-ventricular delay (msec) 10±7 25±26 40±28* 22±7
Systolic Blood pressure (mmHg) 113±19 113±21 114±19 107±20
Cardiac Index (l/min/m2) 7.5±5.2 7±3.8 7±4 6.9±4.3
RV dP/dT (mmHg/s) 417±208 426±184 435±203 348±87
* p<0.05 compared to baseline
† Change in activation time = Absolute delay compared to baseline
 
967-113 Do Changes in Systolic Myocardial Velocities Precede 
Changes in Ejection Phase Indices of Ventricular 
Systolic Performance in Duchenne Muscular 
Dystrophy?
Richard V. Williams, Michael D. Puchalski, Kevin M. Flanigan, Alice L. Olson, Shala M. 
Smith, Lloyd Y. Tani, L. LuAnn Minich, University of Utah, Salt Lake City, UT, Primary 
Children’s Medical Center, Salt Lake City, UT
Background: Boys with Duchenne muscular dystrophy (DMD) are at risk for developing 
a dilated cardiomyopathy in a time dependent fashion. Our purposes were to assess 
myocardial velocities, using Doppler tissue imaging, and to determine their relationship to 
age in DMD patients with normal left ventricular fractional shortening (LV FS) compared 
to normals. Methods: Echos were performed in 35 boys with DMD with LV FS >28% 
and 20 age-matched normal boys. Systolic myocardial velocities were assessed at the 
lateral (LV sys) and medial (Sept sys) mitral annulus, and lateral tricuspid annulus (RV 
sys). DMD and normals were compared using a t-test or rank sum test as appropriate. 
Linear regression analysis was used to assess the relationship of age to LV sys and 
LV FS in the 2 groups. Results: Demographics, LV FS and myocardial velocities are 
shown in the Table. The 2 groups were similar in age and LV FS, but BSA was greater in 
normals. Systolic velocities at all sites were lower in the DMD group. There was a positive 
correlation between LV sys and age in controls (r = 0.6, p = 0.006), but not in the DMD 
group (r = 0.1, p = ns). There was a negative correlation between age and LV FS in the 
DMD group (r = -0.3, p = 0.05), but not in controls (r = -0.1, p = ns). Conclusions: These 
ﬁndings suggest abnormal ventricular performance in the DMD group despite normal 
LV FS. The age dependent increase in LV sys that is absent in DMD patients suggests 
changes in myocardial velocities predate changes in LV FS, and may be useful in serial 
follow-up of these patients.
DMD vs Normals
DMD (n=35) Normals (n=20) p
Age (years) 10.2 ± 4.3 12.2 ± 4.1 ns
BSA (m2) 1.10 ± 0.42 1.47 ± 0.42 <0.05
LV FS (%) 35 ± 3 37 ± 5 ns
LV sys (cm/sec) 9.6 ± 1.8 12.8 ± 2.3 <0.001
RV sys (cm/sec) 12.7 ± 1.5 14.4 ± 2.1 0.002
Sept sys (cm/sec) 7.7 ± 1.3 8.9 ± 1.4 0.001
 
967-114 Tricuspid Annular and Septal Doppler Tissue Velocities 
are Reduced in Pediatric Heart Transplant Recipients
Ritu Sachdeva, Sadia Malik, Renee A. Bornemeier, Sylvia Angtuaco, James G. Parker, 
Elzabeth A. Frazier, Arkansas Children’s Hospital, Little Rock, AR
Background: Cardiac function is known to progressively worsen over time in heart 
transplant (Tx) recipients. Doppler Tissue imaging (DTI) is useful in quantiﬁcation of 
regional myocardial function. Purpose of this study was to determine abnormalities in 
myocardial tissue velocities in pediatric heart Tx recipients without allograft rejection
Methods: Eighty-ﬁve patients were prospectively enrolled for the study; 58 recipients 
of pediatric (< 18y) heart Tx without evidence of rejection and 27 healthy age-matched 
controls. DTI was performed to obtain peak systolic (S), early (E) and late (A) diastolic 
velocities at the tricuspid annulus, septum and mitral annulus. An average of 3 cardiac 
cycles was taken for each echo parameter.
Results: Mean age of the Tx group was comparable to controls (9.6 + 5y vs 8.4 + 4.7y, 
p = 0.29). Shortening fraction by M-mode was similar in both groups. The mean tissue 
velocities (cm/sec) at tricuspid annulus were signiﬁcantly reduced in Tx group compared 
to controls; S was 9.5 + 2 vs 13.6 + 1.2 (p<0.001); E 12.1 + 3.6 vs 14.6 + 1.5 (p<0.001); 
A 7.5 + 1.9 vs 9.6 + 1.1 (p<0.001). The mean septal S and E were reduced in Tx group; 
S was 7.3 + 1.4 vs 8.5 + 1.1, p <0.001; E 11.1 + 1.9 vs 12.8 + 2.3 (p=0.0018); A 5.5 + 1.1 
vs 5.8 + 0.5 (p= 0.06). Mitral annular velocities were not signiﬁcantly different between 
Tx group vs controls (S was 8.8 + 2.2 vs 9.2 + 1.8; E 16 + 3.2 vs 16.5 + 2.5; A 7.5 + 1.9 
vs 6.4 + 0.7).
Conclusions: Tricuspid annular and septal Doppler tissue velocities are signiﬁcantly 
reduced in pediatric heart Tx recipients in the absence of allograft rejection. These 
patients are now being followed longitudinally to determine if decreased tissue velocities 
are a risk factor/or an early marker for rejection.
967-115 Congenital Heart Disease and Late Mortality Following 
Pediatric Heart Transplantation
Christopher S. Almond, Elizabeth D. Blume, Leslie Smoot, Heather J. Bastardi, John E. 
Mayer, Jr., Leslie M. Higuchi, Ravi R. Thiagarajan, Children’s Hospital Boston, Boston, MA
BACKGROUND Data suggests that 1 and 5-year survival following pediatric heart 
transplantation is superior for children transplanted for primary cardiomyopathy compared 
to children transplanted for congenital heart disease (CHD). We sought to determine 
whether CHD persists as an independent risk factor for late mortality 15 years post-
transplant.
METHODS. We performed a retrospective chart review of children who underwent 
pediatric heart transplantation at Children’s Hospital Boston between 1986 and 2004. The 
primary outcome variable was survival at 15 years post-transplant. Univariate (log-rank, 
Cox regression) and multivariate Cox regression analyses were performed to identify 
independent risk factors for mortality at 15 years post-transplant. A best subsets option 
was used to choose the optimal model for the non-primary covariates. The hazard for 
CHD was modeled as a function of time since transplant.
RESULTS Between 1986 and 2004, 148 children underwent heart transplantation for 
end-stage cardiac disease at a single institution. The median age at transplant was 8.7 
years (range 17 days to 23 years). Half (76/148) were transplanted for CHD. One-third 
(48/148) were transplanted before 1995. Overall, one-third (44/148) died during the 15-
year follow-up period. In multivariate analysis, 15-year mortality was associated with a 
diagnosis of CHD (HR 2.04, 95% CI 1.09-3.8), post-transplant mechanical support (HR 
12.6, 95% CI 5.2-30.7), and transplant before 1995 (HR 3.2, 95% CI 1.4-1.7); 15-year 
mortality was not associated with age, sex, listing status, pre-sensitization, or PTLD. The 
hazard function for CHD peaked below 1 year, and again 12 years post-transplant.
CONCLUSION Congenital heart disease is an independent risk factor for late mortality 
following pediatric heart transplantation. The risk attributable to CHD may be biphasic, 
peaking both early and late after transplant. These ﬁndings merit validation in the larger, 
multi-center experience.
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967-116 Prevalence and Risk Factors for Renal Insufﬁciency 
in Pediatric Heart Transplant Recipients: A Long-Term 
Follow-Up Study
Ritu Sachdeva, Elizabeth A. Frazier, Kathryn A. Ainley, James G. Parker, William R. 
Morrow, Arkansas Children’s Hospital, Little Rock, AR
Background: Renal insufﬁciency (RI) is a known complication in heart transplant (Tx) 
recipients. We sought to determine the prevalence and risk factors for renal insufﬁciency 
in pediatric heart Tx recipients over a long term follow up period.
Methods: Study cohort included heart Tx recipients < 21y, with a minimum follow-up 
of 1y. Data was obtained from pre-Tx evaluation and at 1, 6 and 12 mo post-Tx, and 
yearly thereafter. RI was deﬁned as glomerular ﬁltration rate (GFR) < 75 ml/min/1.73 m2 
(Schwartz formula), chronic dialysis or renal Tx. Factors evaluated included gender, race, 
body mass index (BMI), age at Tx, cardiac diagnosis, duration of listing, use of assist 
devices, inotropic support, calcineurin-inhibitors, and rejection episodes.
Results: Study cohort was formed by 77 patients (35 females; 18 Black). Mean age at 
transplant was 4.6y (0.04-19y) with mean follow-up duration of 5.6y (1-14y). Forty two 
developed RI at a mean of 1.6y (0.07-8.7y) after Tx. Median GFR was 93.7 ml/min/1.73 m2 
at Tx and 111, 94.3 and 79.8 ml/min/1.73 m2 at 1, 5 and 10y post-Tx respectively. RI was 
prevalent in 33% pre-Tx; and 18%, 29.5% and 40% at 1, 5 and 10y Post-Tx respectively. 
One patient each required chronic dialysis and renal Tx. The actuarial freedom from RI 
at 1, 5 and 10y was 66%, 43% and 27% respectively. Signiﬁcant risk factors for RI were 
Black race (p=0.04), younger age at Tx (p=0.007), duration of listing (p<0.0001), pre-Tx 
GFR (p<0.0001), time since Tx (p=0.006) and levels of calcineurin-inhibitors (p=0.003). 
Gender, BMI, cardiac diagnosis, assist device, inotropic support and rejection episodes 
were not signiﬁcantly related to RI. The probability of death was not signiﬁcantly different 
in those with or without RI.
Conclusions: Prevalence of RI increases during long-term follow-up of pediatric heart Tx 
recipients. Black race, younger age at Tx, longer duration of listing, pre-Tx RI, and higher 
levels of calcineurin-inhibitors are signiﬁcant risk factors for RI.
POSTER SESSION
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From Noninvasive Methodology to 
Practice Outcomes
Monday, March 13, 2006, 1:30 p.m.-5:00 p.m.
Georgia World Congress Center, Hall B1
Presentation Hour: 3:30 p.m.-4:30 p.m.
989-109 Near Infra-red Spectroscopy is a Reliable Indicator of 
Systemic Perfusion for Unsedated Infants with Single 
Ventricle Physiology
Paul M. Kirshbom, Joseph M. Forbess, Brian E. Kogon, Janet M. Simsic, Dennis W. 
Kim, Anthony A. Raviele, Kirk R. Kanter, Robert N. Vincent, Emory University School of 
Medicine, Atlanta, GA, Childrens Healthcare of Atlanta, Atlanta, GA
Background: Clinical assessment of systemic perfusion in single ventricle patients can 
be difﬁcult in the outpatient setting. Near infra-red spectroscopy (NIRS) is a non-invasive 
measure of cerebral oximetry (a surrogate for mixed venous oxygen saturation). We 
tested the hypothesis that NIRS in awake single ventricle patients is a better predictor of 
superior vena cava saturation (SVC sat) than standard outpatient clinical markers.
Methods: Twenty single ventricle patients had NIRS and vital signs (heart rate, blood 
pressure, pulse oximetry) measured in triplicate prior to routine cath. Superior vena cava 
oxygen saturation (SVC sat) was measured during cath.
Results: Age was 6.7 ± 8.6 months and weight was 6.5 ± 2.2 kg. Diagnoses were 
hypoplastic left heart syndrome (8), tricuspid or pulmonary atresia (10), and double outlet 
right ventricle variants (2), all prior to cavo-pulmonary palliation. Pre-cath NIRS (51.1 
± 9.5%) correlated with SVC sat (52.1 ± 7.7 %) (r=0.62, p=0.004). Stepwise multiple 
regression of all pre-cath variables generated a model in which pre-cath NIRS was the 
only signiﬁcant predictor of SVC sat (F-ratio=11.2, p=0.004).
Conclusion: NIRS is a better marker of systemic perfusion in awake single ventricle 
patients than pulse oximetry, blood pressure, or heart rate. NIRS could be useful for clinic 
or emergency room evaluation of such infants.
989-110 Mesenteric Regional Oximetry in Neonates Undergoing 
Cardiac Surgery: A New Assessment Methodology 
of Systemic Oxygen Delivery Using Near-Infared 
Spectroscopy
Gary E. Stapleton, Brian K. Eble, Debora L. East, Antonio R. Mott, Heather A. Dickerson, 
Jack F. Price, E. Dean McKenzie, Charles D. Fraser, Dean B. Andropoulos, Anthony C. 
Chang, Baylor College of Medicine, Houston, TX
Background: Neonates who require surgery for congenital heart disease (CHD) are at 
increased risk for morbidity and mortality due to poor systemic O2 delivery. Non-invasive 
measurement of regional oxygenation using near-infrared spectroscopy (NIRS) may be 
used to monitor systemic O2 delivery in the perioperative period.
Methods: Neonates with CHD were enrolled prior to cardiac surgery. A NIRS sensor 
(Somanetics 5100B, Troy, MI) was placed on the right forehead and midline lower 
abdomen. Cerebral (crSO2) and mesenteric (mrSO2) regional O2 saturations were 
recorded continuously for 24 hours preoperatively and 48 hours postoperatively.
Results: Twenty-nine patients were enrolled. Ten had hypoplastic left heart syndrome 
and underwent a Norwood operation (Group I). Nineteen had a biventricular repair (Group 
II), including 12 with transposition of the great arteries.
Table 1. Mean Regional Oxygen Saturations
n
Preoperative 
mrSO2
Postoperative 
mrSO2
p value
Preoperative 
crSO2
Postoperative 
crSO2
p value
Group I 10 48.0 52.6 0.34 60.7 49.9 0.002
Group II 19 42.5 63.7 <0.001 58.5 67.9 <0.001
Three group I patients had poor outcomes (2 late deaths, 1 ECMO), and had signiﬁcantly 
lower postoperative mrSO2 compared to the rest of group I (39.1 vs 54.7, p=0.01). One 
group II patient developed acute renal failure postoperatively, and had signiﬁcantly lower 
mrSO2 compared to the rest of group II (41.1 vs 65, p=0.01).
Conclusions: A signiﬁcant decrease in postoperative mrSO2 is associated with increased 
risk of morbidity and mortality in neonates in the postoperative period. Identiﬁcation of 
patients with poor systemic O2 delivery in the perioperative period using NIRS may allow 
early intervention, and improved long-term outcomes.
989-111 Pediatric Impedance Cardiography: Is it reliable?
Christopher L. Lindblade, Marcus S. Schamberger, Eric S. Ebenroth, Anjan S. Batra, 
Indiana University, J.W. Riley Hospital for Children, Indianapolis, IN
BACKGROUND: Impedance cardiography (ICG) provides a continuous, noninvasive 
measurement of cardiac index (CI) that has been useful in the intensive care setting in 
adults. However, there is limited data in its application to children. The purpose of this study 
was to validate a now commercially available ICG system in children. METHODS: Twenty-
two patients (59% male; mean age 4.2 ± 5.0 years) with biventricular circulation without 
signiﬁcant residual shunting were prospectively studied during cardiac catheterization or 
post-operative recovery in the intensive care unit. Oxygen consumption was measured 
by indirect calorimetry, while mixed venous and arterial saturations were drawn from 
existing catheters. Echo measurement of CI was determined by pulsed Doppler and 2-D 
diameter measurement of the left ventricular outﬂow tract. Repeated ICG and echo CI 
measurements were performed simultaneously with Fick measurement while the patient 
was hemodynamically stable. Serial ICG and Fick measurement of CI was performed 
over a 12 hour period immediately post-operatively in selected patients. RESULTS: The 
intraclass correlation coefﬁcient, a measure of reproducibility, for ICG and echo was 
0.96 and 0.97, respectively. The interclass coefﬁcient from blinded peer review of the 
echocardiographic-derived CI was 0.80 indicating high validity in echo measurements. 
CI correlation was as follows: Fick vs. ICG (r = 0.82), echo vs. ICG (r = 0.39), and Fick 
vs. echo (r = 0.37). The mean Fick CI measurement was 3.85 ± 1.36 L/min/m2. ICG 
underestimated Fick and echo CI measurement on average by 0.95 ± 0.80 and 0.67 ± 
1.60 L/min/m2, respectively. ICG and Fick measurement of CI closely trended over the 12 
hour post-operative period. CONCLUSIONS: Repeated ICG measurements of CI have 
better reproducibility and better correlation to the direct Fick method when compared to 
echo measurements in children. ICG has shown to follow the trend in Fick estimation of 
CI during the immediate post-operative recovery period. In conclusion, ICG is a reliable 
tool of predicting CI in children with the advantage of being technically easy, continuous, 
and noninvasive.
989-112 Myocardial Thickness and Pulmonary Vein Flow 
Impedance: Correlation During Fetal Life
Paulo Zielinsky, Antônio L. Piccoli, Jr., João L. Manica, Luiz H. Nicoloso, Dirlene Melo, 
Juliana Zanettini, Vinícius Oliveira, Renato Frajndlich, Rafaella Petraco, Fernanda 
Scarpa, Rebeca S. Wachholz, Laura Hagemann, André Busato, Institute of Cardiology 
of Rio Grande do Sul/FUC, Porto Alegre, RS, Brazil
Background: Pulmonary vein pulsatility index (PVPI), a measure of vascular impedance 
to pulmonary vein ﬂow in the left atrium, has shown to be higher in fetuses of mothers 
with diabetes than in fetuses of normoglicemic mothers. This change is secondary to 
impaired compliance due to myocardial hypertrophy. The correlation between the degree 
of fetal myocardial hypertrophy and PVPI has not been evaluated. Objective: To assess 
the correlation between interventricular septal (IVS) thickness and PVPI in a series of 
fetuses of mothers with pre-existing or gestational diabetes mellitus (group 1) and of 
mothers with normal glucose levels (group 2).
Methods: This cross-sectional study examined 181 fetuses of mothers with diabetes and 
normoglicemic levels. PVPI was obtained using pulsed Doppler and calculated using the 
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formula = maximum [systolic or diastolic] velocity minus minimum [presystolic]/ mean 
velocity. Pearson linear correlation was used for statistical analysis, and critical alpha 
was set at 0.05.
Results: Mean PVPI was 1.06 ± 0.42 (0.40-2.60) and mean IVS thickness was 0.29 ± 
0.08 (0.18-0.62). A signiﬁcant linear correlation was found between these two parameters 
(r = 0.637, p<0.0001). The correlation was also signiﬁcant when groups 1 and 2 were 
compared. The correlation remained statistically signiﬁcant when the sample was 
analyzed according to different gestational age subgroups.
Conclusions: Vascular impedance to ﬂow from the pulmonary veins to the left atrium 
is directly proportional to IVS thickness in fetuses of mothers with and without diabetes, 
expressing progressive changes in left ventricular diastolic function as the degree of 
myocardial hypertrophy increases.
989-113 Assessment of Fetal Ventricular Volume by Dynamic 
3D/4D Echocardiography in Normal Fetuses
Ling Hui, Christine S. Sahn, Petra S. Niemann, Solange Wyatt, David J. Sahn, Oregon 
Health & Science University, Portland, OR
Background: Dynamic ungated 4D fetal echocardiography, if high enough in resolution, 
could allow direct measurement of right and left ventricular (RV, LV) volumes without 
geometric assumptions.
Methods: We studied 30 consecutive normal pregnancies (20-37 weeks EGA) during 
routine obstetric services at OHSU. Optimized dynamic spatiotemporal correlation 
volumes of the fetal thorax and cardiac chambers were rapidly acquired at 8-11 MHz 
on a GE/Voluson 730 Expert system and later analyzed for RV and LV volumes using a 
radial summation technique from epicardial and endocardial traces on an ofﬂine GE 4D 
view program.
Results: Measurable images from 27 of these studies allowed development of normal 
values for RV and LV volumes from 24 weeks gestation to term. RV EDV ranged from 
0.95 to 4.00 ml and RV ESV from 0.45 to 1.78 ml. Mean RV EF was 0.64 ± 0.08. LV EDD 
ranged from 0.73 to 3.18 ml, LV ESD from 0.32 to 1.53 ml and mean LV EF was 0.56 ± 
0.08, but dimensions increased with EGA. On the whole, both RV and LV EF had a lower 
slope when graphed against EGA and rose linearly.
Conclusions: Non-gated fast 4D fetal echocardiography is an acceptable modality for 
determining cardiac chamber wall volume. The method should be especially valuable as 
an objective serial measurement in clinical fetal studies with structurally or functionally 
abnormal hearts.
989-114 Does Normalization for Body Size Variables Actually 
Work in a Pediatric Population?
Tomas G. Neilan, Aruna D. Pradhan, Arthur E. Weyman, Massachusetts General 
Hospital, Boston, MA
Background: Physiological variables and the size of cardiac chambers vary with body 
dimensions (height (HT), weight (WT), body surface area (BSA), and body mass index 
(BMI)). Therefore, it is practice to correct for differences in body size by the process of 
scaling or normalization of a physiological variable, such as cardiac dimensions, to body 
size, via isometric methods. This involves dividing the variable of interest by a body size 
parameter, usually to the ﬁrst power, and assumes a linear, proportional relationship 
between the variables, which may be ﬂawed. Differences in scaling parameters between 
children and adults has also been reported and the relationship of scaling parameters for 
these groups in unknown. Using left atrial dimensions (LAD), we examined the optimal 
scaling technique in a large group of pediatric echocardiographic normals.
Methods: We studied 4109 consecutive echocardiographically normal children <18 
years. Mean age 9±5 years; LAD 26±5 mm; BW 36±20 kg; HT 1.3±0.3 m; BSA 1.1±0.5 
m2; BMI 18±3 kg/m2. LAD was normalized by each size variable using both the isometric 
and allometric methods.
Results: LAD correlated with all size variables (r=0.55 to r=0.77). Simple isometric 
normalization (e.g. LAD/BSA) actually increased the correlation with all body size 
variables (r=-0.57 to -0.92). Correction by the optimal allometric exponent (AE) (BW= 
0.252; HT=0.591; BSA = 0.348; BMI= 0.600) removed the effects of the indexed variable 
with BW and BSA best removing the effects of all measures of body size. The proportion 
of variance of LAD explained by BW was 60% compared to only 28% for BMI, while the 
proportion of variance explained by HT was 57% in children compared to <4% in an 
earlier study of adults. There were minimal, but statistically signiﬁcant, age and gender-
related differences in the AE (e.g. BW AE for males = 0.255 vs. females 0.246).
Conclusions: Isometric corrections for body size are inaccurate and actually increase the 
relationship of the indexed parameter to all body size measures. Conversely, correction 
using the optimal AE removes the effect of that variable, with WT best removing the effect 
of body size. In children, WT accounts for the largest percentage of the variance in LAD.
989-115 Who Needs Gadolinium? Three-Dimensional 
Reconstruction Utilizing Steady State Free Precession 
Cardiac Magnetic Resonance in Congenital Heart 
Disease
Mark A. Fogel, Michaela Schmidt, The Childrens Hospital of Philadelphia, Philadelphia, 
PA, Siemens Medical Systems, Malvern, PA
Background: 3-dimensional (3D) reconstruction utilizing cardiac magnetic resonance 
(CMR) depends upon gadolinium injection. Contrast between the cardiovascular tree 
and the surrounding tissue enables volume rendering. Steady state free precession 
(SSFP) imaging also depends upon contrast between the cardiovascular tree and the 
surrounding tissues, however, no contrast agents are needed, obviating the need for 
needles and contrast agents.
Purpose/Methods: To determine whether 3D reconstructions can be created from SSFP 
imaging and to compare with gadolinium ones, 14 pts (4.5 + 4.8 years old) with congenital 
heart disease underwent T2 prepped SSFP imaging with post processing of the images 
using volume rendering techniques. 9 pts had 3D reconstruction utilizing gadolinium for 
comparison.
Results: Lesions included single ventricle after bidirectional Glenn, coarctation repair 
using ascending to descending aortic conduit, and scimitar syndrome to name a few. 
All 3D reconstructions utilizing T2 prepped SSFP were successful and the salient 
anatomy demonstrated. No difference in image quality was apparent between the 3D 
reconstructions utilizing T2 prepped SSFP and ones utilizing gadolinium enhancement 
(see images below of a 2.5 year old).
Conclusions: 3D reconstruction utilizing T2 prepped SSFP can be performed successfully 
with the same image quality as gadolinium enhanced 3D reconstructions. Gadolinium 
may not be needed for 3D reconstruction, which will improve pt safety and comfort.
989-116 Dobutamine Stress Echocardiographic Assessment of 
Left Ventricular Function Long After Intervention for 
Coronary Artery Fistula
Ling Hui, AKT Chau, MP Leung, YF Cheung, Grantham Hospital, The University of Hong 
Kong, Hong Kong, Hong Kong
Objectives: Patients with persistent coronary artery ﬁstula (CAF) can lead to myocardial 
ischemia. After restoration of myocardial perfusion following intervention, their LV function 
has not been thoroughly studied. We used dobutamine stress echocardiography to assess 
LV function in children with CAF long after intervention of their ﬁstula.
Methods: Eighteen asymptomatic patients (17.04 ± 9.2 years) with CAF who had 
interventions (surgery =14, embolization =4) at the age of 5.3±4.3 years were studied. 
Their pathology involved either the left coronary artery draining to the RV (n=8), the RA 
(n=4), or the right coronary artery to the LA (n=2), the RV (n=2), and the RA (n=2). 
LV contractility was assessed by fractional shortening (FS), ejection fraction (EF), 
stress-velocity index [rate-corrected velocity of circumferential ﬁbre shortening (Vcfc) 
vs wall stress (WS)], and wall motion abnormalities both at rest and under dobutamine 
stress (5µg/kg/min). The results were compared to those of 20 normal subjects aged 
10.4±4.5 years (p=0.34). Univariate analysis was used to identify risk factors for impaired 
contractility.
Results: No wall motion abnormalities were detected at rest or under stress. The resting 
indices, FS (0.38±0.03 vs 0.41±0.05, p=0.06), EF (0.78±0.08 vs 0.80±0.06, p=0.24), and 
Vcfc (1.2±0.1 vs 1.2±0.2, p=0.42), with the exception of WS (59±14 vs 73±12, p<0.01), 
were not signiﬁcantly different between the patients and controls. The stressed FS 
(0.46±0.05 vs 0.54±0.04, p<0.01), EF (0.85±0.06 vs 0.90±0.03, p=0.02), Vcfc (1.6±0.3 
vs 1.7±0.3, p=0.03) and WS (43±11 vs 46±16, p=0.01) were all signiﬁcantly lower in CAF 
patients. At rest, the stress-velocity index was normal for all patients. When stressed, 
this was signiﬁcantly lower (<-2SD) in 4 patients (22%). No pre- or post-operative factors 
could be associated with the impaired LV contractility.
Conclusions: Under dobutamine stress, LV contractility indices were abnormal in all 
the CAF patients long after their intervention. In addition, 22% demonstrated abnormal 
stress-velocity index under stress. Despite apparent full recovery from intervention, the 
long-term LV function of CAF patients needs careful monitoring.
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From Physiology to Outcomes
Tuesday, March 14, 2006, 8:30 a.m.-Noon
Georgia World Congress Center, Hall B1
Presentation Hour: 11:00 a.m.-Noon
1011-109 Vasoreactive Response to Maternal Hyperoxygenation 
in the Fetus with Hypoplastic Left Heart Syndrome
Anita Szwast, Zhiyun Tian, Margaret McCann, Denise Donaghue, Jack Rychik, The 
Fetal Heart Program at The Cardiac Center at The Children’s Hospital of Philadelphia, 
Philadelphia, PA
Background: Cardio-pulmonary interactions play an important role in the pathophysiology 
of hypoplastic left heart syndrome (HLHS). Pulmonary vasculopathy has been identiﬁed, 
in particular in those with restrictive atrial septum. Responsiveness of the pulmonary 
vasculature to maternal hyperoxygenation (MH) may provide a tool to assess the degree 
of pulmonary vasculopathy present prior to birth.
Methods: Doppler echocardiography was performed in normal (NL) (n=9) and HLHS 
(n=19) fetuses. In HLHS, sampling was repeated after 10 minutes of MH with 60% FiO2, 
and after 5 minutes of recovery. Sampling was performed in the proximal, mid-portion, 
and distal (intraparenchymal) branch pulmonary artery (PA). Pulsatility index (PI) was 
used as a measure of vascular resistance.
Results: Middle cerebral artery (MCA) PI was lower in HLHS vs NL. There was no 
difference in umbilical artery (UA), ductus arteriosus (DA) or branch PA PI between 
NL and HLHS. MH led to a signiﬁcant decrease in PI at each of the PA sites sampled. 
There was no relationship between gestational age and magnitude of response to MH; 
vasoreactivity was noted as early as 24 weeks. No change in UA, MCA, or DA PI was 
noted with MH. Cardiac output in HLHS was less than NL, and did not change with MH. 
No untoward effects were seen with MH.
Conclusions: PA vasoreactivity to MH occurs in the fetus with HLHS. MH may be used 
to assess the fetus with restrictive atrial septum thereby stratifying outcome and gauging 
efﬁcacy of fetal atrial septoplasty.
NL
HLHS-
RA
HLHS-O2 
(MH)
GA (weeks)
28.4 
(5.8)
29.7 
(4.9)
29.7 (4.9)
Weight (gm)
1085 
(862)
1538 
(792)
1538 (792)
UA PI
1.16 
(0.17)
1.26 
(0.21)
1.32 (0.25)
MCA PI
2.05 
(0.30)#
1.72 
(0.26)#
1.72 (0.23)
DA PI
2.86 
(0.23)
2.80 
(0.32)
2.93 (0.24)
Prox Branch PA PI
3.35 
(0.60)
3.51 
(0.52)**
2.89 (0.57)**
Mid Branch PA PI
3.78 
(0.44)
3.74 
(0.56)**
3.14(0.58)**
Distal Branch PA PI
4.29 
(0.78)
4.13 
(0.55)**
3.39 (0.48)**
Cardiac Output (Combined or Right 
Ventricle) (ml/min/kg)
461 
(45)#
380 
(124)#
375 (119)
#=p<0.05 Normal vs. HLHS_RA, **=p<0.01 HLHS_RA vs. HLHS_O2
 
1011-110 HMG-CoA Reductase Inhibitors Are Effective for 
Prevention of Acute Coronary Artery Injury in a Rabbit 
Model of Kawasaki disease
Sei-ichiro Ozawa, Kenji Hamaoka, Kyoto Prefectural University of Medicine Graduate, 
Kyoto, Japan
Background:Therapy with HMG-CoA reductase inhibitors has been shown to signiﬁcantly 
reduce major coronary events. Recent observations also suggest that some of the 
clinical beneﬁts associated with statin therapy may be pleiotropic. In this study, we tried 
to evaluate the availability of statins mediated through their inhibitory and suppressive 
effects on inﬂammation in Kawasaki disease model rabbits
Methods:An animal model was established by the intravenous administration of horse 
serum twice to juvenile rabbits. Rabbits were further divided into 3 groups: no treatment 
group (A), those treated with ﬂuvastatin (B) and those with pravastatin (C) on days 3 prior 
to the second administration.
Results:In group A, histological examination demonstrated a marked mononuclear 
cell inﬁltration in the intima and adventitia, disruption of the internal elastic lamina, and 
intracellular edema in the medial smooth muscle cell layer, which were similar to the 
histopathological features of Kawasaki disease. These changes were most prominent on 
days 3 (Fig. A) and persisted until after days 14 (Fig. B). On the other hand, in both group 
B and C, those given statins were initially expressed mononuclear cell inﬁltration but this 
peaked on days 3 (Fig. C) and 7. Treatment with statins improved the vascular thickening 
on days 7 and 14 (Fig. D).
Conclusions:These results suggest that HMG-CoA reductase inhibitors are effective for 
prevention of the acute phase of panvasculitis in the animal model of Kawasaki disease.
1011-111 Systemic Oxygen Saturation and Coagulation Factor 
Abnormalities Before and After the Fontan Procedure
Eddie W Y Cheung, Yiu-fai Cheung, Cardiac Paediatric Unit, Grantham Hospital, Hong 
Kong, Hong Kong
Background: Coagulation factor abnormalities are thought to predispose to increased 
risk of thromboembolism after the Fontan procedure. Recent data, however, suggest that 
coagulation abnormalities may precede the operation. We determined the coagulation 
factor abnormalities in patients with a single-ventricle congenital heart defect prior to the 
Fontan procedure and compared the ﬁndings with age-matched post-Fontan patients and 
control subjects.
Methods: The liver function, coagulation factor levels and pulse oximetry readings were 
determined in 11 pre-Fontan patients aged 9.3 ± 5.6 years. The results were compared 
to those of 11 age-matched post Fontan patients, at 9.1 ± 2.4 years after the Fontan 
procedure, and 11 age-matched controls by simple analysis of variance and post hoc 
Tukey test.
Results: The liver function was normal in patients before and after surgery apart from 
a mildly elevated bilirubin level in post Fontan patient (p = 0.027). When compared 
with controls, pre-Fontan patients had signiﬁcantly lower levels of protein C, protein S, 
antithrombin III, factors II, V, VII and X, and longer prothrombin times (all with p <0.05). 
When compared with post Fontan patients, pre-Fontan patients had similarly lower levels 
of free protein S (p <0.001), protein C (p = 0.06) and antithrombin III (p = 0.001). The 
systemic oxygen saturation correlated positively with the levels of anticoagulants (protein 
C, protein S, antithrombin III) and procoagulants (factors II, V, VII, X) (all with p <0.05, r 
between 0.33 and 0.61).
Conclusions: Our ﬁndings suggest that coagulation factor abnormalities precede the 
Fontan procedure and tend to normalize after the operation, relating perhaps to improved 
systemic oxygenation.
1011-112 Flow Proﬁles Across the Right Ventricle to Pulmonary 
Artery Shunt and Ventricular Mechanics in Hypoplastic 
Left Heart Syndrome
Geoffrey A. Forbus, Scott M. Bradley, Andrew M. Atz, Girish S. Shirali, Medical University 
of South Carolina, Charleston, SC
Background: With the recent introduction of the right ventricle to pulmonary artery shunt 
(RV-PAS) for palliation of hypoplastic left heart syndrome (HLHS), concerns have been 
raised regarding the impact of shunt regurgitation on RV function. We studied prograde 
and retrograde ﬂow across the RV-PA shunt, and examined the effect of this shunt on 
RV mechanics. Methods: Between 5/04 and 12/04, we studied 15 patients who had 
undergone RV-PAS as part of Stage I palliation for HLHS. During the echocardiogram 
performed prior to cavopulmonary anastomosis, Doppler interrogation of the RV-PAS and 
the neo-aortic valve was recorded with simultaneous phonocardiography to time the ﬁrst 
and second heart sounds. The diameters of the shunt and the neo-aortic valve annulus 
were recorded. The following durations were measured: R-R interval, duration of RV 
isovolumic contraction and relaxation, prograde and regurgitant ﬂow through the shunt 
and prograde ﬂow through the neo-aortic valve. The time velocity integrals (TVI) of each 
of these ﬂows were measured. Values are reported as mean +/- SD. Student’s t-test was 
used for comparisons.
Results: Prograde ﬂow into the RV-PAS extended signiﬁcantly longer through the cardiac 
cycle than did prograde neo-aortic ﬂow (60 +/- 4% vs. 47 +/- 6% of the cardiac cycle, 
p<0.001). The duration and TVI of RV-PA shunt prograde ﬂow was signiﬁcantly greater 
than that of regurgitant ﬂow (263 +/- 36 msec vs. 174 +/- 32 msec respectively, p<0.001, 
and 52 +/- 17 cm vs. 10 +/- 4 cm respectively, p<0.001). The ratio of duration of RV-PA 
shunt prograde ﬂow to regurgitant ﬂow was 1.55 +/- 0.25, and the ratio of prograde TVI 
to regurgitant TVI was 5.44 +/- 1.94. Prograde RV-PA shunt ﬂow started before S1 in 7 
patients and at S1 in the remaining 8; it extended beyond S2 in all cases by 40 +/- 18 
msec. No pt had any measurable isovolumic contraction or relaxation time.
Conclusions: The RV-PAS is associated with unique patterns of PA ﬂow. Prograde ﬂow 
from the RV extends signiﬁcantly longer through the cardiac cycle into the PAs than it 
does into the systemic circulation. Shunt regurgitation is minimal. The implications of 
elimination of isovolumic phases of RV contraction and relaxation bear further study.
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1011-113 Comparison of Autonomic Control Between Atrial 
Septal Defect and Ventricular Septal Defect Based on 
Heart Rate Variability and Respiration
Tadayoshi Hata, Fujita Health University, Toyoake, Japan
Background: Ventricular septal defect (VSD) and atrial septal defect (ASD), exhibit 
increased pulmonary blood ﬂow through the left-to-right shunt. In patients with these 
pathological states arising from volume and/or pressure overload in the right heart can 
result in sympathovagal imbalance that may be reﬂected in heart rate variability (HRV). We 
investigated the correlation between the HRV and respiratory frequency characteristics, 
and left-to-right shunt ratio (Qp/Qs) measured by the Doppler echocardiography.
Methods: We enrolled 78 patients. Diagnoses were: VSD (n=33) and ASD (n=45). 
Mean age was 5.6 ± 3.3 years, mean body weight 16.9 ± 8.7 kg. Electrocardiogram and 
respiratory waves were recorded during the Doppler echocardiography test. We performed 
HRV analysis using Acknowledge ver. 3.9 (CA, USA) to calculate low frequency power 
(LF), high frequency (HF), total frequency (TF), respiratory frequency (RF), the ratio of 
low to high frequency power (LF/HF), the ratio of total to respiratory frequency power 
(RF/TF), and the ratio of low to respiratory frequency power (LF/RF). Shunt ratio (Qp/Qs) 
was also calculated from the Doppler echocardiography and quantiﬁed by multivariate 
analysis with HRV parameters. JMP software (CA, USA) was used for analyses, and 
ANOVA and unpaired t-test for signiﬁcance tests.
Results: 1) Qp/Qs and LF/HF, indices of sympathetic nerve activity based on 
sympathovagal balance, exhibited correlation in both ASD and VSD groups. 2) The 
ASD group showed a positive correlation between Qp/Qs and LF/RF (indices of balance 
between sympathetic nerve and respiratory vagal activities). However, in the VSD 
group the correlation was negative. 3) Qp/Qs correlated negatively with RF/TF (a ratio 
of respiratory vagal power to total frequency power), in the ASD group, however, the 
correlation was positive in the VSD group.
Conclusion: ASD and VSD showed different effects of respiratory vagal activity on heart 
rate variability. We believe that a reason is that volume and low pressure overload to the 
right atrium in ASD inhibits respiratory vagal innervation of the sinus node, while the 
overload to the left atrium in VSD does not.
1011-114 Endothelial Dysfunction and Therapeutic Strategy in 
Adult Cyanotic Congenital Heart Disease Patients: 
Assessment of Noninvasive Study
Jun Furui, Masahiro Ishii, Yayoi Nakahata, Kitasato University, Sagamihara, Japan, 
Tsuchiya, Hiroshima, Japan
Background: Endothelial function is important issue to provide the prognosis of long-
term in adult patients (pts) with cyanotic congenital heart disease (CHD). We assessed 
the endothelial function in young adult pts with cyanotic CHD noninvasively. And we 
investigated clinical utility of a new therapeutic strategy using vitamin C (Vit.C) on 
endothelium. Methods: Eighteen pts with cyanotic CHD (age 24 +- 1.4 years, 10 males, 
8 female) including 6 pts with pulmonary atresia and intact ventricular septum, 4 pts 
with atrioventricular septal defect, 4 pts with pulmonary atresia with tetralogy of Fallot, 
2 pts with tricuspid atresia, and 2 pts with asplenia syndrome were studied. Age and 
sex-matched 12 healthy subjects (25 +- 1.8years, 6males. 6 female) were studied as 
control. The oxygen saturation of CHD pts was 72.8 +- 6.1% (66-82%). Eight pts are in 
I (the classiﬁcation of NYHA), 6 pts in II, and 4 pts in III. Flow-mediated dilatation (FMD, 
endothelium-dependent) of brachial artery was measured by high resolution ultrasound 
Doppler echocardiography system (ALOKA SSD-5500) before and after intravenous 
administration of Vit.C (2g). Results: At baseline, FMD in pts with cyanotic CHD was 
signiﬁcantly impaired (3.3 +- 4%) as compared with control pts (18.2 +- 6%, p<0.05). After 
intravenous administration of Vit.C, FMD in pts with cyanotic CHD signiﬁcantly increased 
to 12 +- 5% (p<0.05). There was no signiﬁcant difference in nitroglycerin induced dilation 
(NTG-D, endothelium independent) between 2 groups (pts with cyanotic CHD; 21 +- 20% 
vs. control pts: 27 +- 7%, p=NS). In all pts treated with oral Vit.C (2g/day) during 4-6 
months, FMD signiﬁcantly increased from baseline (9.4+-3.0%, p < 0.05). Conclusions: 
Endothelial dysfunction in young adults with cyanotic CHD was existed. The administration 
of Vit.C, which is known as an antioxidant, improve endothelial dysfunction. This therapy 
may become a new therapeutic strategy to prevent the development of atherosclerosis in 
adult pts with cyanotic CHD
1011-115 Right Ventricular Remodeling as a Result of Pulmonary 
Valve Replacement in Adult Fallot Patients Is Closely 
Related to Baseline Right Ventricular Size
Ivo R. Henkens, Alexander Van Straten, Martin J. Schalij, Ernst E. Van der Wall, Albert 
De Roos, Hubert W. Vliegen, Leiden University Medical Center, Leiden, The Netherlands
Background: After total correction, Fallot patients with important pulmonary regurgitation 
beneﬁt from pulmonary valve replacement (PVR), resulting in reverse remodeling of the 
right ventricle (RV). Optimal timing of PVR has been subject of debate for several years. 
Predicting results of PVR is important for deciding when to intervene in these patients.
Methods: A Group of 26 adult Fallot patients had an MRI both prior to PVR and after 
PVR (average interval 2.5 years, range 0.8-4.4. years). From these, volumetric and 
functional RV parameters were derived, and differences between measurements 
calculated. Parameters were indexed for Body Surface Area (BSA) of the patients, to 
allow comparison regardless of patient size.
Results: Baseline RV Index (RV end-diastolic volume indexed for BSA) was the strongest 
predictor of improvement, showing excellent correlation with change in RV Index (r = 0.86, 
p< 0.001) and RV Index after PVR (r = 0.79, p< 0.001).
Conclusions: Baseline RV Index is the most reliable predictor of outcome of PVR, 
with respect to RV volume decline. However, despite a decrease in RV Index after PVR 
proportionate to baseline RV Index, larger ventricles remain larger. This may imply that a 
certain degree of ﬁbrosis precludes RV remodeling beyond a certain point. Consequently, 
earlier PVR will likely result in lower RV volumes after PVR, preserving RV function.
1011-116 The Effect of Ramipril and Valsartan on Aortic Stiffness 
and Wave Reﬂections in Patients With Successful 
Coarctation Repair
Stella Brili, Nikolaos Alexopoulos, Nikolaos Ioakeimidis, Ioanna Dima, Charalambos 
Vlachopoulos, John Barbetseas, Dimitrios Tousoulis, Christodoulos Stefanadis, Athens 
Medical School, Hippokration Hospital, Athens, Greece
Background: Patients after successful coarctation repair (SCR) have increased incidence 
of cardiovascular complications mostly due to relapse of hypertension. This relapse is 
attributed to the impaired elastic properties of the upper body arteries. It is well known that 
angiotensin converting enzyme inhibitors and angiotensin receptor antagonists reduce 
aortic stiffness and wave reﬂections indices, however their effect on arterial stiffness in 
postcoarctectomy patients has not been studied yet.
Methods: 12 patients, 25±6 years old with SCR at 14±7 years, which were normotensive 
at rest, were studied at 4 different occasions with a randomized, cross-over design: (i) at 
baseline and 4 weeks after ramipril 5 mg once a day; (ii) at baseline and 4 weeks after 
valsartan 160 mg once a day. Carotid-femoral pulse wave velocity (PWV) was measured 
as an index of aortic stiffness with Complior®. Wave reﬂections were studied with 
Sphygmocor®, which from the radial pressure waveform (obtained by arterial tonometry) 
synthesize the aortic pressure waveform. Augmentation index (AIx) was measured as an 
index of wave reﬂections.
Results: Both ramipril and valsartan decreased peripheral blood pressure (systolic 
by 7.6±9 and 5.9±7 mmHg respectively, P<0.05 for both, diastolic by 6.5±5 and 9.1±6 
mmHg respectively, P<0.01 and <0.005 respectively). PWV and AIx were also decreased 
with ramipril and valsartan (PWV by 0.5±0.3 and 0.6±0.6 m/sec, P<0.005 and <0.01 
respectively; AIx by 5.2±4 and 5.8±4 respectively, P<0.005 for both). When the effect 
of ramipril on systolic and diastolic pressure, PWV, and AIx was compared to that of 
valsartan, no difference was observed in any parameter (exept of a trend of valsartan to 
decrease diastolic pressure more than ramipril, P=0.07).
Conclusions: Ramipril and valsartan reduce aortic stiffness and wave reﬂections to the 
same degree in patients after SCR. Their beneﬁcial effect on arterial stiffness should be 
taken into account when treatment in SCR patients is considered.
ORAL CONTRIBUTIONS
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Congenital Heart Disease and Pediatric 
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Georgia World Congress Center, Room B406
9:15 a.m.
840-4 Healthcare Resource Utilization in Adults with 
Congenital Heart Disease: A Population-Based Study
Andrew S. Mackie, Louise Pilote, Raluca Ionescu-Ittu, Elham Rahme, Ariane J. Marelli, 
McGill University Health Centre, Montreal, Canada
Background: The number of adults with congenital heart disease (CHD) is increasing. 
However, rates of healthcare resource utilization among this population are not known. 
The purpose of this study was to describe the use of healthcare resources among adults 
with CHD and to determine the impact of CHD severity on resource utilization.
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Methods: The study consisted of persons ≥18 years of age and alive on January 1, 
1996 who had at least one diagnostic code of a CHD lesion between 1983-2000 
conforming to the International Classiﬁcation of Disease, 9th Revision in the physician’s 
claims database of Quebec. Patients were classiﬁed as having “severe” CHD if they 
had a univentricular heart, tetralogy of Fallot, an atrioventricular canal defect, truncus 
arteriosus, or transposition of the great arteries. All remaining lesions were classiﬁed as 
“other” CHD. During the interval 1996-2000 inclusive, rates of healthcare utilization were 
measured. The impact of CHD severity on use of healthcare resources was determined in 
multivariate models adjusting for age, gender, Charlson co-morbidity score, and presence 
of a terminal illness. Over a 12-month period in 1999-2000, rate of hospitalization/1,000 
persons was compared to the general population of Quebec.
Results: The study consisted of 22,096 adults with CHD, of which 1, 765 (8%) had severe 
lesions. Among the entire population, 51% were hospitalized one or more times between 
1996-2000, 16% were admitted to a critical care unit, 68% visited an emergency room, 
89% received outpatient specialist care, and 91% received outpatient primary care. 
Persons with severe CHD had higher rates of outpatient specialty care (RR 1.25, 95% 
CI 1.19- 1.32), emergency department utilization (1.10, 1.03- 1.17), hospitalization (1.31, 
1.20- 1.44), and days in intensive care (2.06, 1.74- 2.44) than persons with other lesions. 
The annual hospitalization rate in 1999-2000 was higher in the age and gender-matched 
CHD population (2.62, 2.52- 2.72) than in the general Quebec population.
Conclusions: Adults with CHD have high rates of healthcare resource utilization, 
particularly those with severe lesions. Appropriate resource allocation is required to serve 
this growing population.
9:27 a.m.
840-5 Abnormal Ventilatory Response to Exercise Predicts 
Mortality in Adult Congenital Heart Disease Patients
Konstantinos Dimopoulos, Gerhard-Paul Diller, Darlington O. Okonko, Tushar V. Salukhe, 
Massimo F. Piepoli, Michael A. Gatzoulis, Adult Congenital Heart Disease Unit, Royal 
Brompton Hospital, London, United Kingdom
Background: In patients with acquired heart failure, ventilatory efﬁciency (VE/VCO2 
slope) is a powerful prognostic marker. We set out to establish whether VE/VCO2 slope is 
abnormal in adult congenital heart disease (ACHD) and relates to outcomes.
Methods and Results: 560 consecutive patients with congenital heart disease underwent 
cardiopulmonary exercise testing between 2001 and 2004. Patient age was 33.2±12.9 
years (mean±SD), peak VO2 23.5±9.0 ml/kg/min and VE/VCO2 slope 36.3±15.3. Mean 
follow-up was 21.7±11.8 months. At the end of follow-up, 25 patients had died.
VE/VCO2 slope was raised in all ACHD groups and was highest in patients with 
Eisenmenger physiology (68.5±20.8). VE/VCO2 slope was 73% higher in patients with 
cyanosis than in those without (56.7±23.2 versus 32.7±9.8, p<0.0001). Cyanosis was the 
strongest independent predictor of VE/VCO2 slope (increment in VEVCO2 associated 
with cyanosis = 18.6, p<0.0001), separate from the effect of pVO2 (decrement in VE/
VCO2 per kg/ml/min of pVO2 = 0.64, p<0.0001).
In the non-cyanotic population, VE/VCO2 slope was the most powerful predictor of 
mortality. On univariate analysis, the signiﬁcant predictors were VE/VCO2 slope (HR 
1.079 per unit, 95% CI 1.039-1.121), pVO2 (HR 0.900 per ml/kg/min, 95% CI 0.836-
0.969), peak pulse (HR 0.982 per unit, 95% CI 0.967-0.998). On stepwise multivariate 
analysis the only signiﬁcant predictor was VE/VCO2 slope. In the cyanotic population, 
none of the variables predicted survival. If the cyanotic and non-cyanotic populations were 
merged, signiﬁcant univariate predictors of prognosis were VE/VCO2 slope (HR 1.036 
per unit, 95% CI 1.019-1.052), pVO2 (HR 0.891 per ml/kg/min, 95% CI 0.839-0.946), rest 
pulse (HR 1.027 per unit, 95% CI 1.001-1.054), and peak pulse (HR 0.979 per unit, 95% 
CI 0.968-0.991). On multivariate analysis, only pVO2 was predictive of survival
Conclusions: Abnormal ventilatory response to exercise is present across the spectrum 
of ACHD. Cyanosis is a powerful stimulus for abnormal ventilatory pattern. VE/VCO2 
slope is a strong predictor of death, carrying additional independent prognostic value to 
pVO2 across the spectrum of ACHD in patients without cyanosis.
9:39 a.m.
840-6 Bosentan Improves Hemodynamics and Exercise 
Capacity in Eisenmenger Physiology
Michael Landzberg, BACH Pulmonary Hypertension Service, Boston, MA
Background: Eisenmenger physiology (EP) associated with complex congenital heart 
defects is characterized by high pulmonary artery pressure and ﬁxed pulmonary vascular 
resistance causing right-to-left intracardiac shunting. EP is not amenable to conventional 
treatment or surgery. Endothelin (ET), a vasoconstrictive and proliferative peptide, has 
been shown to contribute to the pathology of pulmonary arterial hypertension (PAH). 
As bosentan (Tracleer®), a dual ETA/ETB receptor antagonist, has been shown to be 
effective in PAH, we tested the hypothesis that bosentan could improve cardio-pulmonary 
hemodynamics and exercise capacity in patients with EP.
Methods: This multi-center, randomized, double-blind, placebo-controlled study, 
evaluated oxygen saturation (ﬁnger oximetry), hemodynamics (catheterization) and 
exercise capacity in WHO functional class III patients.
Results: Fifty-four patients with stable disease for at least 3 months were randomized 
2:1 to bosentan (n = 37) or placebo (n = 17). Similar distribution of ventricular or atrial 
septal defects was observed in both treatment groups (65%, 22%, bosentan; 71%, 29%, 
placebo). In addition 13% in the bosentan group had a combined defect. The mean time 
from EP diagnosis was 24 and 21 years in the bosentan and placebo group, respectively. 
After 16 weeks, bosentan treatment effect (bosentan effect minus placebo effect) was 
-472 (S.E. 222) dyn·sec·cm-5 95% CI=[-918, -27] (p = 0.04) on pulmonary vascular 
resistance indexed, and -5.5 (2.5) mmHg (p = 0.04) on mean pulmonary arterial pressure. 
The treatment effect on the indexed pulmonary to systemic blood ﬂow ratio (Qpi/Qsi) was 
-0.1 (0.1), indicating no change in the shunt. Accordingly, oxygen saturation was stable. 
Treatment effect on 6-minute walk distance was 34 (14) m 95% CI=[6, 61] (p=0.02). 
Consistent with the known safety proﬁle, 59% placebo and 81% bosentan patients had at 
least one adverse event, with 2 discontinuations each.
Conclusion: In this ﬁrst placebo-controlled trial in EP patients, bosentan improved 
pulmonary hemodynamics and exercise capacity with stable oxygen saturation. These 
results suggest bosentan is an important new treatment option for patients with EP.
9:51 a.m.
840-7 Early Initiation of Perindopril Preserves Left Ventricular 
Ejection Fraction and Decreases Mortality in Duchenne 
Muscular Dystrophy: Results After Ten-Years Follow-Up
Bertrand Pierre, Christophe Meune, Karim Wahbi, Annick Toutain, Carole Berard, Guy 
Vaksmann, Henri-Marc Bécane, Bruno Eymard, Simon Weber, Denis Duboc, Cochin 
Hospital, Paris, France
Background: Duchenne Muscular dystrophy (DMD), an X-linked disorder, is characterized 
by progressive respiratory failure, muscle weakness and constant myocardial alteration, 
responsible of death in 40% of patients. We previously demonstrated that early treatment 
with perindopril prevented the onset and progression of left ventricular (LV) dysfunction. Our 
aim was to assess the long-term effects of early administration of perindopril on mortality.
Methods: Children between 9.5 and 13 years of age, with DMD and normal LVEF were 
included in a 3-year randomized, double-blind trial and received perindopril 2-4mg/day 
or placebo, with a 2-year open-label follow-up with perindopril at the highest tolerated 
dose. All patients were maintained on perindopril after the whole 5-year period. We 
report a post-hoc analysis of mortality during a further 5-years prospective follow-up (10 
years in total). Vital status information was collected from all families and practitioners or 
administrative ﬁles if data were lacking.
Results: 57 children (10.7±1.2 years, LVEF 65.0±5.4%) were included and randomized 
to perindopril (group 1, n=28) or placebo (group 2, n=29). Baseline characteristics did 
not differ between groups at baseline; at 60 months, a single patient in group 1 had 
LVEF<45% versus 8 in group 2(p=0.02). Mortality data were available for all children and 
was as follows: 3 children died in group 2 versus 0 in group 1 after 2 years (p=0.08), 4 in 
group 2 versus 1 in group 1 after 4 years (p=0.17) and 10 in group 2 versus 2 in group 
1 after 5 years of additional follow-up (p=0.009). Kaplan-Meier cumulative survival was 
signiﬁcantly reduced in group 2 initially assigned to placebo when compared to group 1 
(logrank test p=0.013). By multivariate analysis including age at inclusion, beta-blocker 
treatment and random assignment to study treatment, random assignment to perindopril 
or placebo was the only parameter associated with mortality (p=0.031).
Conclusions: Early treatment with perindopril signiﬁcantly reduces mortality when 
compared to delayed treatment initiation in DMD patients with normal LVEF at inclusion.
10:03 a.m.
840-8 Obesity is Prevalent, and is a Signiﬁcant Additional 
Comorbidity in Children With Congenital and Acquired 
Heart Disease
Nelangi M. Pinto, Bradley S. Marino, Gil Wernovsky, Sarah DeFerranti, Amy Z. Walsh, 
Laurie Armsby, Kristen Hyland, Meryl S. Cohen, Children’s Hospital of Philadelphia, 
Philadelphia, PA, Boston Children’s Hospital, Boston, MA
Background: Obesity is a pediatric epidemic with numerous health implications, and may 
pose additional cardiovascular risk to children with acquired and congenital heart disease 
(CHD). Many children with CHD are restricted from physical activity. There is no data to 
deﬁne the scope of the potential threat of obesity within the CHD population.
Methods: A cross-sectional review of 1055 randomly selected outpatients (age 6-19 y) 
evaluated in 2004 was performed. Differences in the prevalence of obesity (body mass 
index [BMI] ≥95%) and at risk for obesity (BMI ≥85%-95%) in the cohort were compared to 
national prevalence data with the two-sample test of proportions. Dichotomous variables 
were compared utilizing Fisher’s exact test.
Results: Mean age was 13 ± 3.6 y. Diagnoses included CHD s/p biventricular repair 
(n=188); CHD s/p Fontan (n=48); electrophysiologic disease (n=220); heart transplantion 
(n=32); and a control group without signiﬁcant heart disease (n=485). Results are shown 
in Figure 1. The only group with signiﬁcantly fewer obese and at risk for obesity patients 
was the Fontan group.
Conclusions: Excluding the Fontan population, the outpatient pediatric cardiac 
population is at no less risk for obesity than the national population giving them additional 
risk factors for long-term cardiovascular disability. Careful consideration should be given 
to limiting physical activities in CHD patients, weighing the potential risks of exercise 
against those of a sedentary lifestyle.
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840-9 Risk Factors for Coronary Artery Involvement in 
Children After Kawasaki Disease
Brian W. McCrindle, Andrew M. Atz, Steven D. Colan, Welton M. Gersony, Jennifer S. 
Li, L. LuAnn Minich, Paul D. Mitchell, Masato Takahashi, Victoria L. Vetter, Jane W. 
Newburger, The Hospital for Sick Children, Toronto, ON, Canada, for the NHLBI/NIH 
Pediatric Heart Network
Background: Kawasaki disease (KD) is associated with a spectrum of coronary artery 
(CA) involvement, yet reported analyses for risk factors have used arbitrarily-deﬁned 
Japanese Ministry of Health criteria. We sought to evaluate CA abnormalities as a 
continuous variable using serial normalized Z scores, and to determine clinical and 
laboratory associated factors.
Methods: As part of the NHLBI/NIH Pediatric Heart Network clinical trial of acute steroid 
use, we used mixed linear regression analyses of serial standardized adjudicated echos 
measuring Z scores of the proximal right main (RCA) and left anterior descending (LAD) 
over a 5 week period.
Results: Of the 199 subjects enrolled, 190 remained eligible with acceptable studies. The 
mean age was 3.3 + 2.2 years at the acute episode, 62% were male, and 51% received 
a single dose of steroid in addition to standard IVIG and aspirin. Overall, the median 
maximum Z score decreased from +1.43 at baseline, to +1.25 at 1 week and to +1.05 at 5 
weeks. During the study 26% had at least one Z score > +2.5, while 5% had at least one > 
+5 (only 3 patients had an absolute dimension at any time above 4 mm, none 8 or above). 
One additional patient with normal proximal dimensions had an isolated aneurysm in 
the mid-RCA. When the baseline Z score was < +2.5, it remained so during follow-up 
in 94%. When the baseline Z score was > +2.5, it remained so during follow-up in 78%. 
Regression analysis showed a signiﬁcant decrease in Z scores over time (p<0.001), 
and higher Z scores in the RCA versus LAD (p=0.01). Additional independent factors 
associated with higher Z scores during the study included younger age (particularly <1 
year; p<0.001), greater days from fever onset to IVIG treatment (p=0.01), lower IgM at 
baseline (p=0.02), and lower overall minimum albumin (p<0.001). After controlling for 
these factors, Z scores were not signiﬁcantly related to any other management, clinical 
or laboratory factor.
Conclusions: Using serial normalized CA measurements, abnormalities at follow-up 
are highly associated with baseline dimensions. Other independent factors associated 
with greater normalized CA dimensions are similar to those reported for aneurysms by 
Japanese Ministry of Health criteria.
POSTER SESSION
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1035-109 Epidemiologic Features of the Presentation of Critical 
Congenital Heart Disease: Implications for Screening
Amy H. Schultz, Bernard J. Clark, III, A. Russell Localio, Chitra Ravishankar, Nancy 
Videon, Stephen E. Kimmel, Children’s Hospital & Regional Medical Center, Seattle, 
WA, University of Pennsylvania School of Medicine, Philadelphia, PA
Background: Critical congenital heart disease (CCHD) requires invasive intervention in 
the ﬁrst month of life, occurs in ~1/1000 live births, can be difﬁcult to detect by physical 
exam and if unrecognized can lead to shock or death. Although postnatal screening for 
CCHD has been proposed, the incidence of decompensation and the time available for 
screening must be deﬁned to assess the potential impact and feasibility of screening.
Methods: A retrospective cohort of neonates with CCHD admitted to Children’s Hospital 
of Philadelphia from 1/00-6/03 was reviewed. Exclusion criteria were severe non-cardiac 
anomalies, withdrawal of support without organ injury, and isolated patent ductus arteriosus 
in a preterm infant. Included subjects were classiﬁed as decompensated if they met ≥1 
of the following criteria preoperatively: cardiac arrest, seizure, severe metabolic acidosis 
(arterial base deﬁcit ≥10, non-arterial base deﬁcit ≥15), ALT ≥150 U/L or AST ≥450 U/L, 
or creatinine ≥2 mg/dL. Cardiologists blinded to outcome classiﬁed decompensation as 
preventable by a hypothetical postnatal screening strategy if it occurred after 12h of age 
due to undiagnosed CCHD. To minimize referral bias, we also analyzed a subgroup that 
lived locally and were from a consistent referral source (“local, consistent referrals”).
Results: Of 490 subjects, 15.5% (95% CI 12.4-19.0%) had decompensation and 6.7% 
(95% CI 4.7-9.3%) had preventable decompensation. Local, consistent referrals had a 
decompensation rate of 12.7%, all others 18.2% (p=0.09). Preventable decompensation 
occurred in 3.8% of local, consistent referrals. Of 40 subjects who decompensated due to 
undiagnosed CCHD, 85% ﬁrst met criteria after 12h of age, 73% after 24h of age. 91% of 
cases of preventable decompensation had aortic arch obstruction.
Conclusions: The incidence of decompensation due to CCHD potentially preventable by 
postnatal screening is ~1/15,000-1/26,000 live births, similar to that of several disorders 
for which newborn screening is established. Few neonates with undiagnosed CCHD 
decompensate before 12h of age, allowing time for screening. A viable screening strategy 
must be sensitive for lesions with aortic arch obstruction.
1035-110 The Changing Age Distribution of Severe Congenital 
Heart Disease in the General Population
Ariane J. Marelli, Andrew S. Mackie, Raluca Ionescu-Ittu, Elham Rahme, Louise Pilote, 
McGill University Health Center, Montreal, PQ, Canada
Background: Little empirical data exists on the changing epidemiology of congenital heart 
disease (CHD) in the general population. Our goal was to compare median age, prevalence 
and proportion of adults relative to children with severe CHD from 1985 to 2000.
Methods: We used administrative databases which record all health related claims in 
accordance with the International Classiﬁcation of Disease, 9th Revision. We deﬁned 
“severe” CHD to include: tetralogy of Fallot; truncus arteriosus; transposition complexes; 
endocardial cushion defects and univentricular hearts. Children were subjects <18 years 
old. Prevalence rates were determined in children and adults in l985, 1990, 1995 and 
2000 using population data in Quebec, Canada. Prevalence ratios (PR) were calculated 
by dividing the prevalence in 2000 by the prevalence in 1985.
Results: The population-based prevalence of CHD in year 2000 was 5.78/1000 for all 
CHD, of which 0.61/1000 (11%) was severe CHD. The median age of patients with severe 
CHD was 11 years (inter-quartile range: 4, 22) in 1985 and 17 years (inter-quartile range: 
10, 28) in 2000 (p<0.0001). Prevalence is reported for severe CHD per 1,000 population.
 
1985 2000
Severe (N) Prevalence Severe (N) Prevalence
PR (95% conﬁdence 
interval)
Children 1,963 1.19 2,316 1.45 1.22 (1.15 - 1.30)
Adults 1,035 0.21 2,205 0.38 1.81 (1.72 - 2.00)
Conclusions: The prevalence of severe CHD increased between 1985-2000 but the 
increase in adults was signiﬁcantly higher than that observed in children. By the year 2000 
there were a nearly equal number of children and adults with severe CHD in the general 
population. These results are consistent with changing survival of patients with CHD.
1035-111 Differences in Health Awareness Knowledge, 
Environmental Tobacco Smoke Exposure (ETS), and 
Body-Shape Perception Among Adolescents Based 
Upon Body Mass Index (BMI)
Thomas E. Vanhecke, Wendy M. Miller, Barry A. Franklin, Jim E. Weber, Peter A. 
McCullough, William Beaumont Hospital, Royal Oak, MI
Background: The obesity pandemic has created calculable cardiovascular disease risk 
in the adolescent population. We sought to assess the general health knowledge, self-
perception of body-shape, eating habits, exercise and ETS exposure of adolescents and 
its relationship to BMI.
Methods: We designed and administered a survey to collect data on demographics, 
assess general health knowledge, exercise, eating habits, ETS exposure, and assess 
perceptions of lifetime risk in adolescents. Using CDC age and sex speciﬁc nomograms 
for BMI, adolescents were categorized by percentiles as underweight (<5th percentile), 
normal weight (5th to 85th percentiles), overweight (85th to 95th percentiles), or obese 
(>95th percentile).
Results: Students, n = 814, (47% male, mean age 15.6 yrs) from four Michigan high 
schools participated in the survey. Mean BMI of participants was 23.5 kg/m2 with 64.6% 
of participants were classiﬁed as normal, 18.8% were obese, 15.7% were overweight, 
and 0.9% were underweight. Almost 37% of overweight and 88% of non-overweight 
participants perceived themselves as average or very-low body fat. A minority of 
overweight and non-overweight participants (22.8 vs. 3.1%) view themselves as being 
overweight or obese. When asked to select the greatest perceived health risk they will 
face in their lifetime, overweight compared to non-overweight participants selected 
cancer more frequently (32 vs. 24%, p=0.011), and accidents less frequently (27 vs. 43%, 
p=0.018). When asked about frequency of ETS exposure, overweight compared to the 
non-overweight adolescents were more likely to be choose “2-3 times per week” (17.4% 
vs. 10.3%, p=0.007) and less likely to select “almost never” (26.8% vs. 19.8%, p=0.047). 
No difference was observed in the frequency of physical activity, fast food and soda intake 
by self-report.
Conclusions: Differences in lifetime disease risk perception, ETS exposure and general 
health knowledge exist based upon BMI among adolescents. Overweight adolescents 
have a higher frequency of ETS exposure than non-overweight adolescents. These data 
may be useful in tailoring future population-speciﬁc prevention strategies.
1035-112 Myocardial Infarction in Adolescents
William T. Mahle, Robert M. Campbell, Jennifer Favaloro-Sabatier, Children’s Healthcare 
of Atlanta, Emory University School of Medicine, Atlanta, GA, Rollins School of Public 
Health, Emory University, Atlanta, GA
Background: Though considered rare, acute myocardial infarction (AMI) can occur in 
adolescents. AMI may be considered in the differential diagnosis of chest pain, which 
itself accounts for >550,000 emergency department evaluations in adolescents each year 
in the US. The incidence of AMI in adolescents, however, has not been reported.
Methods: We analyzed data from the National Inpatient Sample (NIS) to determine the 
incidence of AMI in adolescents (13-18 yrs). NIS is an inpatient database approximating 
a 20% stratiﬁed sample of U.S. hospitals. Data from 1998-2002 were analyzed. Patients 
with primary cardiomyopathies or congenital heart lesions were excluded.
Results: There were 41 adolescents with a hospital discharge diagnosis of AMI. The 
estimated incidence was 42 AMI admissions in adolescents per year in the US or 
1.8 events/1,000,000 patient-years. Associated diagnoses or conditions included: 
amphetamine and/or cocaine abuse 16 (33%), congenital coronary anomaly 5 (13%), 
Kawasaki’s disease 2 (4%), and other causes 5 (13%). In 13 subjects (32%) an associated 
condition or risk factor for premature AMI was not reported. AMI occurred predominantly 
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in males (83%). Coronary angiography was performed in 23 subjects (56%) and coronary 
artery bypass graft surgery in 3 subjects (7%). The hospital mortality was 2%. The mean 
length of stay was 3.8+/-2.1 days.
Conclusions: AMI is extremely rare in adolescents and often occurs in association with 
substance abuse. The hospital survival is excellent and the need for coronary surgical 
intervention is uncommon.
1035-113 Attitudes Toward Management of the Hypoplastic 
Left Heart Syndrome Among Pediatric Nurses and 
Residents
Pierangelo Renella, Ruey-Kang R. Chang, Robert D. Bart, David A. Ferry, Mark S. 
Sklansky, Childrens Hosptial Los Angeles, Los Angeles, CA, Mattel Children’s Hospital, 
University of California at Los Angeles Medical Center, Los Angeles, CA
Background: Improved surgical outcomes in the hypoplastic left heart syndrome (HLHS) 
impact the approach to counseling pregnant women with affected fetuses and may 
discourage caregivers from offering comfort care for affected newborns.
Objective: To determine the factors inﬂuencing personal decisions of pediatric residents 
and nurses in the management of HLHS, were they themselves parents of an affected 
fetus or newborn.
Methods: Pediatric residents and nurses from 3 local pediatric cardiac centers completed 
an anonymous questionnaire surveying their views on HLHS management. Respondents 
were given hypothetical scenarios in which they were parents of a fetus or newborn with 
HLHS. Multivariate logistic regression was conducted to determine the factors inﬂuencing 
the decisions for termination of pregnancy and surgery using the following independent 
variables: sex, race/ethnicity, religion, marital status, parental status, expected survival 
and quality of life (QOL).
Results: 157 nurses and 23 third-year residents responded. In the case of prenatal 
diagnosis, we found that 43% of residents and 50% of nurses would terminate the 
pregnancy. Expected survival was a strong predictor for choosing termination (p=0.02). In 
the case of postnatal diagnosis, we found that 49% of residents and 68% of nurses would 
either choose or consider comfort care, rather than surgery. Being Asian/Paciﬁc Islander 
(p=0.03), being married (p=0.02), and expected survival (p=0.01) were strong predictors 
for choosing surgery.
Conclusions: Despite improved surgical outcomes, a signiﬁcant portion of pediatric 
residents and nurses would opt for termination of pregnancy or postnatal comfort care 
without surgery were their own fetus or child diagnosed with HLHS. Further, these parental 
decisions are based more upon expected survival, with lesser weight placed on QOL. 
Personal characteristics such as sex, race/ethnicity, religion and parental status are not 
associated with these decisions. As these two groups of caregivers have the most contact 
with affected patients and families, their attitudes on management should be considered 
when counseling families following the prenatal or postnatal diagnosis of HLHS.
1035-114 Outcome Of Prenatally Diagnosed Tricuspid Atresia: A 
Multicenter Experience
Rachel M. Wald, Edythe B. Tham, Brian W. McCrindle, Fionnuala McAuliffe, Edgar 
Jaeggi, Wayne Tworetzky, Lynne E. Nield, The Hospital for Sick Children, Toronto, ON, 
Canada, Boston Children’s Hospital, Boston, MA
Background The natural history of prenatally diagnosed tricuspid atresia (TA) is 
undeﬁned.
Objective To characterize the clinical and echocardiographic features of prenatally 
diagnosed TA.
Methods All cases with a fetal diagnosis of TA from 1990 to 2005 at the two major tertiary 
institutions were reviewed for clinical and fetal echocardiographic data to determine 
factors associated with post-natal mortality in actively managed cases.
Results n=82 were diagnosed at a median gestational age 24 weeks (range 17-38 
weeks). n=20 pregnancies were terminated (24%), 4 pregnancies ended in intrauterine 
fetal demise and 57 were livebirths (median gestational age 37 weeks, range 24-40 
weeks, median birth weight 3 kg, range 1.2-4.2 kg). Atrioventricular and ventriculoatrial 
concordance were present in 20 (35%), pulmonary stenosis in 22 (38%) and aortic arch 
anomalies in 14 (25%). Of those, 5 died as neonates (2 compassionate care; 2 trisomy 
18 and one with multiple anomalies) and one was lost to follow up. Median follow-up of 
patients surviving beyond the ﬁrst day of life was 3.4 years (range 2 days to 13 years). 
n=51 children went on to receive active management: balloon atrial septostomy (n=4), 
pulmonary arterial band (n=6), Blalock Taussig shunt (BTS) (n=24), Norwood palliation 
(n=12), 4 bidirectional cavopulmonary connections (BCPC) and 1 right outﬂow stent. 
Thirty ﬁve children in total have undergone a BCPC and 22 have attained Fontan 
completion. There were 8 deaths among the patients receiving active management 
(16%). Four patients died in hospital of cardiac failure, 1 of acute acidosis and 3 died 
suddenly at home (after BTS). Median age at death was 28 days of age (range 2-324 
days). Kaplan Meier estimates of survival were 90% at 1 month and 83% at 1 year up to 
13 years. The only associated factor signiﬁcant in multivariable analysis was the presence 
of extracardiac anomalies, hazard ratio=9.8, p=0.006. After controlling for this risk factor 
no other factor was independently associated.
Conclusions This is the largest series of prenatally diagnosed cases of TA. Fetal demise 
contributes to overall mortality. Non cardiac vs. cardiac anomalies are more important risk 
factors for mortality in this population.
1035-115 Variant Coronary Artery Pattern and Ventricular Septal 
Defect Are Associated With Chronotropic Impairment 
Late After the Arterial Switch Operation
Sara K. Pasquali, Bradley S. Marino, Michael G. McBride, Gil Wernovsky, Stephen M. 
Paridon, The Children’s Hospital of Philadelphia, Philadelphia, PA
Background: The impact of coronary artery pattern on exercise performance after the 
arterial switch operation (ASO) is unknown. The purpose of this study was to compare 
exercise stress test (EST) parameters in patients with variant and usual coronary 
patterns, as well as to identify other potential risk factors for poor exercise performance 
late after ASO.
Methods: Charts were reviewed on ASO patients who underwent EST at our institution 
from 1/96-4/05. Those with submaximal effort were excluded. Univariate analysis utilized 
t-test and Fisher’s exact test. Linear regression was used to identify risk factors for lower 
maximum heart rate (max HR) and percent of predicted peak oxygen consumption 
(%VO2).
Results: Fifty-three patients were included; 72% were male. Median age at ASO was 5d 
(1d-3.6y); 32% had concurrent ventricular septal defect (VSD) repair. Time from ASO to 
EST was 14.1y (7.7-20.6y). There were 37 patients with the usual coronary pattern, and 16 
(30%) with variant patterns. Demographic and operative data at ASO; and body habitus, 
age, and echocardiographic data at follow-up EST were similar between the 2 groups. 
At EST, there was no difference in respiratory exchange ratio (1.16±0.1 for both groups, 
p=NS) indicating similar effort. HR at rest was also similar (75±8 bpm vs. 74±12 bpm, 
p=NS). Compared to those with the usual coronary pattern, patients with a variant pattern 
had signiﬁcantly lower max HR [177±16 bpm (89% predicted) vs. 186±11 bmp (93% 
predicted), p=0.04] and max work rate (85±18% predicted vs. 99±24% predicted, p=0.02). 
%VO2 was not signiﬁcantly different between the 2 groups (80±17% vs. 89±20%, p=NS). 
In multivariate analysis, variant coronary pattern (p=0.03) and VSD (p=0.004) predicted 
signiﬁcantly lower max HR, and were associated with trends toward lower %VO2 (p<0.1). 
Length of follow-up was also a predictor of lower %VO2 (p<0.001).
Conclusions: Repair of transposition of the great arteries in association with variant 
coronary pattern or VSD results in chronotropic impairment late after ASO. The association 
of lower %VO2 with older age, variant coronary pattern, and VSD suggests that these 
sub-populations may also be at risk for impaired aerobic capacity following ASO.
1035-116 Left Ventricular Myocardial Performance Index is 
Abnormal in Patients With Repaired Tetralogy of Fallot
Omid Salehian, Kwan L. Chan, Ian G. Burwash, Luc M. Beauchesne, University of 
Ottawa, Ottawa, ON, Canada
Background: Although left ventricular (LV) systolic dysfunction has been reported in 
some patients with tetralogy of Fallot (TOF), the underlying pathophysiology has not yet 
been determined. It is thought that subtle degrees of LV dysfunction are present in all 
patients with TOF; however, current echocardiographic methods for assessment fail to 
document it. Myocardial performance index (MPI) has been introduced as a global index 
of ventricular function and might be a more sensitive in assessing ventricular function. We 
set out to study LV function in patients with TOF using MPI.
Methods: Consecutive TOF patients were prospectively recruited and underwent 
complete echocardiographic assessment. LVEF was estimated using Simpson’s biplane 
method. Consecutive patients with normal echocardiograms were chosen as controls.
Results: Forty-two patients (13 female, average age 32.4±12.3 yrs) participated in the 
study. Seventeen had undergone pulmonary homograft implantation (PVR group) an 
average of 3.0 yrs before recruitment. There was no signiﬁcant difference between the 
degree of mitral regurgitation in the three groups. LVEFestimate were not statistically 
different between the three groups (Controls 65.0±7.3%, PVR 62.0±9.4%, and no PVR 
60.0±10%, p=ns). Patients with TOF had signiﬁcantly higher LV MPI than controls (ﬁgure) 
which indicates worse LV function.
Conclusions: Patients with repaired TOF have abnormal LV function assessed by MPI 
despite a normal LVEF.
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Congenital Heart Disease and Pediatric 
Cardiology Highlights: From Innovation 
to Outcomes
Tuesday, March 14, 2006, 2:00 p.m.-3:30 p.m.
Georgia World Congress Center, Room B313
2:15 p.m.
852-4 Novel Non-Implant Radiofrequency Energy Catheter 
Closure of Patent Foramen Ovale in Swine
Phillip Moore, Ted E. Feldman, Hardwin Mead, Ziyad Hijazi, Marian Rippy, Kelley 
Richardson, Dan Francis, Kenneth Horne, Dominique Filloux, Jose Alejandro, Alexis Dineen, 
University of California San Francisco, San Francisco, CA, Cierra Inc, Redwood City, CA
Background: Patent Foramen Ovale (PFO) closure is important for prevention of 
recurrent embolic stroke and new data suggest a role in treatment of migraine headaches. 
Current closure techniques use implantable devices with thrombi, arrhythmia, and erosion 
complications. We hypothesize that the PFO can be safely closed without an implant by 
applying RF energy to fuse the foramenal ﬂap. 
Methods: Using a novel RF catheter (Cierra PFX), closure was performed under 
ﬂuoroscopic and intra-cardiac echo guidance via the femoral vein in 29 pigs (48.5± 9.3kg). 
Native PFO was present in 7 and the septum was crossed at the superior rim of the fossa 
ovalis in 22. Atrial septal pathology was evaluated (n=19) at 7days (n=10), 6weeks (n=4) 
and 3months (n=5). 
Results: RF energy (4 to 36kJ) was successfully applied in all cases and 6 of 7 native 
PFOs closed. PVCs led to ventricular ﬁbrillation in 1 pig during energy application. 
First degree block developed in 2 of the ﬁrst 17 animals. A change in electrode shape 
and procedural improvements eliminated this in the remaining 12 animals. No other 
complications occurred. Recovered animals had normal activity, appetite, and growth. At 
day 7 there was an ellipsoid lesion over the fossa ovalis in the right atrium (1.6x 1.4cm) 
with loss of endothelium (68% of area) and thrombus formation (71% of area). A smaller 
lesion (0.9 x 0.6 cm) was seen on the left atrial side with minimal endothelial loss (7%) 
and thrombus (14%). Central lesion necrosis extended through 73 + 19% of septum. 
The altered electrode resulted in similar lesions with no left atrial surface thrombus at 
7 days. All animals at 6 weeks had healing ﬁbrosis and inﬂammation with complete 
endothelialization of both right and left atrial surfaces without thrombus. At 3 months, 
lesion inﬂammation resolved with ﬁbrosis extending 67 + 26% of septal thickness. There 
were no kidney or lung infarcts. 
Conclusion: RF energy PFO closure with the Cierra PFX System is feasible and safe 
in pigs. Injury to LA septal surface is minimal with complete lesion healing by 6 weeks. 
This novel technique may allow a substantial reduction in PFO closure risk over current 
device implants.
2:27 p.m.
852-5 Real-Time 3-Dimensional Echocardiography for the 
Calculation of Left Ventricular Volumes in Fetuses 
With Aortic Stenosis Being Considered for In-Utero 
Intervention: An In-Vivo, and In-Vitro Validation Study
Brian Soriano, Wayne Tworetzky, Audrey Marshall, Elif Seda Selamet Tierney, Nikolay 
Vasilyev, Martin Hoch, Gerald R. Marx, Children’s Hospital, Boston, MA
Background: Left ventricular volume (LVV) is one parameter used to select fetuses with 
severe aortic stenosis (AS) for in-utero aortic valvuloplasty. LVV is currently calculated 
using two-dimensional echocardiography (2DE) and the hemisphere cylinder method. 
This formula may not be optimal in fetuses with severe AS. We hypothesize real-time 
three-dimensional echocardiography (RT3DE) can accurately measure LV diastolic 
volumes in this population.
Methods: Ten 3D and 2D data sets were retrospectively identiﬁed in subjects with 
severe fetal AS being considered for in-utero intervention. Images were acquired using a 
Philips 7500 RT3DE system. For each subject, 6-8 discs were traced, and volumes were 
calculated by two blinded investigators using dedicated TomTec software. 2DE LVVs were 
also calculated by a blinded observer. To validate RT3DE determination of very small 
volumes, a static balloon and displacement of ﬂuid model was applied in-vitro. 6 small 
balloons were imaged in a water tank and analyzed.
Results: For LVVs, the median by RT3DE was 2.5 ml (range 1.2-5.9) and by 2DE 2.8 
ml (range 0.8-7.9) with no signiﬁcant difference between the two groups (p=0.29). The 
average interobserver variability was 5.0% (SD 5.6%). Y = 0.89 + 0.59x (SEE 0.12, r =0 
.86), where “x” is the 2DE volume. For the static balloon test the actual median volume 
was 1.75 mL (range 0.5 - 3). In-vitro volumes calculated by 2DE were consistently larger 
than RT3DE (mean difference 0.22 mL, 95% CI 0.04 - 0.40 mL, p < 0.03). There was 
no signiﬁcant difference between the actual volumes and RT3DE (p=0.62, Y = -0.006 + 
0.995x, SEE 0.04, r = 0.993).
Conclusions: RT3DE can determine LV volumes in fetuses with severe AS, with 
acceptable interobserver variability. Using in-vitro balloon models, the accuracy of RT3DE 
was found reliable. As expected by mathematical modeling, and due to the more spherical 
nature of left ventricles in severe fetal AS, RT3DE volumes tended to be smaller than 
2DE. RT3DE will enhance patient selection, and can be used in the serial evaluation of 
balloon valvuloplasty in this unique population.
2:39 p.m.
852-6 A Novel Echo-Doppler Method to Predict Diastolic and 
Mean Pulmonary Artery Pressures: Derivation and 
Validation by Catheterization
Mark K. Friedberg, Jeffrey A. Feinstein, David N. Rosenthal, Stanford University, Palo 
Alto, CA
Background: Current non-invasive methods for estimating diastolic and mean pulmonary 
artery pressures (PAp) in children are cumbersome and/or of limited accuracy. We 
hypothesized that diastolic and mean PAp correlate with systolic PAp, allowing prediction 
of diastolic and mean PAp from tricuspid regurgitation (TR) Doppler ﬂow.
Methods: We recorded PAp in 112 pts < 30y catheterized for heart failure, heart 
transplant, pulmonary hypertension (PH) or congenital heart disease. Using regression, 
we derived the relationship of systolic PAp to diastolic and mean PAp. We validated this 
method using TR Doppler-derived PA systolic pressure to calculate PA diastolic and mean 
pressures in 17 pts with PH, and compared the results with catheterization.
Results: A linear relation was seen between PA systolic, and both diastolic (Figure) and 
mean PAp measured at cardiac catheterization (r=0.95, p<0.0001; r=0.97, p<0.0001 
respectively). The calculated diastolic PAp derived from TR Doppler correlated well with 
those measured invasively (31±13 mmHg v 30±11 mmHg, respectively, NS; r=0.85, 
p<0.0001) and was superior to existing methods (Figure). The correlation for mean PAp 
was similar (r=0.86, p<0.0001).
Discussion: A strong linear relationship between PA systolic and diastolic and mean 
pressures allows for easy and accurate non-invasive estimation of PA diastolic and mean 
pressure from TR Doppler ﬂow.
2:51 p.m.
852-7 Congenitally Corrected Transposition of the Great 
Ateries: Intermediate Results of the Anatomic Repair
Janine L. Arruda, Kimberly Brown, Gowdgere Srinath, Larry Latson, Roger Mee, 
Cleveland Clinic Foundation, Cleveland, OH
Background: RV dysfunction, tricuspid regurgitation (TR) and CHF are common later 
in life in patients with congenitally corrected transposition of the great arteries (ccTGA). 
Long-term results of the conventional repair have been discouraging. Early and mid-
term results of the anatomic repair (AR)which consists of a Double switch operation or 
Senning/Rastelli, have been promising. The Cleveland Clinic experience with the AR was 
reviewed.
Methods: 70 patients with ccTGA underwent AR from 1/94-7/05, 44 were male. 
Questionnaires were mailed to patients and their cardiologists were contacted. The most 
recent F/U data was obtained in 54 patients. Functional class (FC), rhythm, degree of 
valvar regurgitation, ventricular function, bafﬂe problems, residual VSD and outﬂow tract 
obstruction were reviewed. Pre, post and late postoperative differences, survival and 
freedom from reoperation were assessed. 
Results: 40 patients (57%) had a DS, and 30 (43%) had a SR. 70% had 1 or more prior 
surgeries. There were 3 deaths (1 early, 2 late). The late survival rate was 95.8%. Median 
age of operation was 2.4y (0.17-16), median length at F/U was 48 m (3-136). 70% of the 
54 patients were in FC I. 73% were in sinus rhythm, 25% were paced. TR and RV function 
improved signiﬁcantly (p<0.001). There was no signiﬁcant worsening of LV function or 
degree of MR. 4 had mild-moderate aortic valve insufﬁciency. There were 4 atrial bafﬂes 
leaks, 4 bafﬂe obstructions, 3 small residual VSDs, and no signiﬁcant LVOT obstruction. 
85% were re-operation free at 5.2 years after the AR. Late re-interventions were TV/MV 
repair/Glen shunt in 1, cardiac transplant 1, subaortic resection 5, conduit replacement 6, 
pacemaker/AICD 1, SVC dilatation 2.
Conclusions: Low early (1.8%) and late (3.7%) mortality was observed with 70% of 
patients in FC I. Early improvement of TR and RV function was maintained with a low 
incidence of late LV dysfunction. As expected, SR patients required conduit replacement 
(20%) and subaortic resection (16.6%). The AR should be considered in selected patients 
over the conventional repair.
3:03 p.m.
852-8 Left Ventricular Dysfunction and Mortality in Patients 
with Eisenmenger Syndrome
Omid Salehian, Markus Schwerzmannn, Sherryn Rambihar, Deborah Silver, Sam Siu, 
Gary Webb, Peter Liu, University of Toronto, Toronto, ON, Canada
Background: It is well established that patients with Eisenmenger syndrome (ES) have 
a shorter life expectancy, and risk factors such as right ventricular hypertrophy (RVH) and 
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presence of complex anatomy have been identiﬁed as high risk features. To date there 
have been no studies reporting the impact of left ventricular dysfunction on survival in 
these patients.
Methods: Medical records and echocardiograms of adult patients with the diagnosis of 
ES from the Toronto Adult Congenital Cardiac Center were reviewed and demographic, 
clinical (signs and symptoms of CHF), and echocardiographic data (LV and RV size and 
function, EF) were collected.
Results: A total of 122 patients (73 females) with ES were studied, 75 of which had 
simple defects (ASD, VSD, or PDA). The median survival was 53.8 years. There were 47 
deaths. Predictors of death using univariate analysis include clinical signs of CHF, RVH 
on electrocardiography, and LV dysfunction (EF <50%). On multivariate Cox regression 
analysis, clinical CHF (Hazard Ratio [HR] 2.26, 95% CI 1.14-4.48), and LV dysfunction 
(HR 3.73, 95% CI 1.69-8.22) remained strong predictors of mortality. Kaplan-Meier 
survival curves are shown for the population based on LVEF ≥50% and <50%.
Conclusions: This is the ﬁrst study to demonstrate that left ventricular dysfunction is a 
strong independent predictor of survival in patients with Eisenmenger syndrome. 
3:15 p.m.
852-9 Predictors of Mortality in Adult Patients with 
Eisenmenger Physiology
Gerhard-Paul Diller, Konstantinos Dimopoulos, Mehmet G. Kaya, Omer Goktekin, Craig 
Broberg, Michael A. Gatzoulis, Adult Congenital Heart Unit, Royal Brompton Hospital, 
London, United Kingdom
Background - With the development of disease-targeting but costly therapies for 
pulmonary arterial hypertension, risk assessment is increasingly required for appropriate 
resource allocation for these patients. We aimed to identify predictors of death in adult 
patients with Eisenmenger physiology.
Methods and Results - We performed a case-control study on Eisenmenger patients 
followed at our center, who died between 2001 and 2005. Each patient was matched with 
a control patient of similar age and underlying anatomy. All data were analyzed blindly. 
Of the 182 Eisenmenger patients present in our database, 18 (8 male) died during this 
period. Underlying cardiac anatomy was non-restrictive ventricular septal defect (VSD) 
in 5, atrial septal defect in 4, common arterial trunk in 4, transposition of great arteries 
with VSD in 3 and patent arterial duct in 2. Mean age at death was 42.3±10.4 years. 
On logistic regression analysis functional (NYHA) class (relative risk = 3.0, p<0.05) 
and presence of signs of heart failure (relative risk = 10.3, p<0.01) as well as history of 
documented arrhythmia (relative risk = 12.4, p<0.05) were found to be predictive of death. 
On ECG, longer QRS duration (relative risk = 1.06, p<0.05) and QTc interval (relative 
risk = 1.06, p<0.05) were associated with a worse outcome. Low albumin (relative risk 
= 0.9, p<0.05), high gGT (relative risk = 1.06, p<0.5) and low potassium levels (relative 
risk = 0.1, p<0.05) were also predictive of mortality. In contrast, neither medication nor 
semiquantitative echocardiographic assessment of right and left ventricular size and 
function were predictive of death. Furthermore, previous history of pulmonary or systemic 
emboli, recurrent pulmonary infections and or hemoptysis and near-syncope or syncope 
were not signiﬁcantly different between the two outcome groups.
Conclusion - Our data suggests that death in Eisenmenger patients can be predicted 
by clinical and laboratory parameters. Predictive value can be found not only in markers 
of progression of heart failure but also in parameters notoriously associated with sudden 
cardiac death and this warrants further investigation.
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